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Abstract  15 
 16 
The Origin Recognition Complex (ORC) cooperates with CDC6, MCM2-7, and CDT1 to form pre-17 
RC complexes at origins of DNA replication. Here we report tiling-sgRNA CRISPR screens that 18 
show that each subunit of ORC and CDC6 are essential in human cells. Using an auxin-inducible 19 
degradation system, stable cell lines were created that ablate ORC2 rapidly, revealing multiple 20 
cell division cycle phenotypes. The primary defect in the absence of ORC2 was cells encountering 21 
difficulty in initiating DNA replication or progressing through the cell division cycle due to reduced 22 
MCM2-7 loading onto chromatin in G1 phase. The nuclei of ORC2 deficient cells were also large, 23 
with decompacted heterochromatin. Some ORC2 deficient cells that completed DNA replication 24 
entered into, but never exited mitosis. ORC1 knockout cells also demonstrated extremely slow 25 
cell proliferation and abnormal cell and nuclear morphology. Thus, ORC proteins and CDC6 are 26 
indispensable for normal cellular proliferation and contribute to nuclear organization. 27 
 28 
Key Words: Initiation of DNA replication, Origin Recognition Complex, pre-Replicative Complex, 29 
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 2 
Introduction 32 
Cell division requires the entire genome to be duplicated once and only once during the S-33 
phase of the cell cycle, followed by segregation of the sister chromatids into two daughter cells. 34 
To ensure the complete and correct duplication of genomes, the initiation of DNA replication is 35 
highly regulated and begins with the assembly of a pre-Replication Complex (pre-RC) at origins 36 
of DNA replication throughout the genome (Bell and Labib, 2016). Among eukaryotes, studies in 37 
Saccharomyces cerevisiae have proved to be the best characterized system, from which 38 
individual proteins involved in DNA replication have been identified and studied extensively, 39 
including reconstitution with purified proteins of pre-RC assembly and the regulated initiation of 40 
DNA replication from pre-RCs (Evrin et al., 2009; Remus et al., 2009; Yeeles et al., 2015). In S. 41 
cerevisiae, pre-RC assembly begins with the hetero-hexameric Origin Recognition Complex 42 
(ORC), comprising Orc1-6 subunits, binding to each potential DNA replication origin (Bell et al., 43 
1993; Bell and Labib, 2016; Bell and Stillman, 1992; Gibson et al., 2006). Chromatin-bound 44 
ORC then provides a platform for the assembly and recruitment for other pre-RC proteins. Cdc6 45 
binds to ORC, followed by the binding of the Cdt1-Mcm2-7 complex to form head-to-head 46 
Mcm2-7 double hexamers to complete the formation of the pre-RC (Araki, 2011; Bell and Labib, 47 
2016; Bleichert et al., 2017; Evrin et al., 2009; Heller et al., 2011; Remus et al., 2009). The 48 
Mcm2-7 double hexamer helicase precursor complex remains bound to DNA in an inactive state 49 
until it is activated by additional proteins and protein kinases (Bell and Labib, 2016). During S 50 
phase, Cyclin-dependent protein kinase (CDK) and the Cdc7-Dbf4-dependent protein kinase 51 
(DDK), Sld2, Mcm10, Dpb11, Sld3/7, DNA polymerase ε, Cdc45 and the GINS complex are 52 
recruited to activate MCM2-7 helicase (Araki, 2016; Araki et al., 1995; Bell and Labib, 2016; 53 
Kamimura, 2001; Kamimura et al., 1998; Takayama et al., 2003; Yeeles et al., 2015). The 54 
functional helicase consists of Cdc45-Mcm2-7-GINS (CMG) and when activated it unwinds the 55 
DNA in a bidirectional and temporally regulated manner from each origin (Bleichert et al., 2017).   56 
In all eukaryote cells, including those from both yeast S. cerevisiae and human, each ORC1-5 57 
subunit consists of a AAA+ or a AAA+-like domain and a winged helix domain (Bleichert et al., 58 
2017; Chen et al., 2008; Li et al., 2018; Ocaña-Pallarès et al., 2020; Tocilj et al., 2017). In yeast, 59 
Orc1-6 remains as a stable complex bound to the chromatin throughout the cell division cycle 60 
(DePamphilis, 2003; Weinreich et al., 1999). ORC binds to A and B1 DNA sequence elements 61 
within the Autonomously Replicating Sequence (ARS), which contains a conserved ARS 62 
Consensus Sequence (ACS) (Bell and Labib, 2016; Bell and Stillman, 1992; Celniker et al., 63 
1984; Deshpande and Newlon, 1992; Marahrens and Stillman, 1992; Rao and Stillman, 1995). 64 
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 3 
On the other hand, in human cells, there is no sequence-specific binding of ORC to the DNA, 65 
and the binding of ORC to chromosomes is dynamic (Vashee et al., 2001). ORC subunits do 66 
localize to specific sites within the chromosome, most likely via interactions with modified 67 
histones (Hossain and Stillman, 2016; Long et al., 2019; Miotto et al., 2016). One or more of the 68 
human ORC subunits dissociate from the complex soon after the pre-RC is formed. For 69 
example, ORC1 is ubiquitinated by the SCFskp2 ubiquitin ligase during the G1-S transition and 70 
then re-appears as cells enter mitosis (Kara et al., 2015; Kreitz et al., 2001; Méndez et al., 2002; 71 
Ohta et al., 2003). Human cell ORC1 is the first ORC subunit to bind to mitotic chromosomes 72 
and is inherited into the daughter cells where it recruits other ORC subunits and CDC6 to form 73 
the new pre-RCs (Kara et al., 2015; Okuno et al., 2001). 74 
ORC is a conserved complex in eukaryotes, and it is essential for DNA replication in S. 75 
cerevisiae, S. pombe, Xenopus and Drosophila, since mutation or depletion of ORC prevents 76 
CDC6 binding and MCM loading onto DNA (Chuang et al., 2002; Pflumm and Botchan, 2001; 77 
Romanowski et al., 1996; Speck et al., 2005). Besides its function in the initiation of DNA 78 
replication, ORC protein subunits also play other important roles. In yeast, Orc1 directly 79 
interacts with silencing regulator Sir1 at the silent mating type loci to mediate transcriptional 80 
gene silencing and maintain heterochromatin (Bell et al., 1993; Fox et al., 1995; Hou et al., 81 
2005; Triolo and Sternglanz, 1996). ORC1 also plays a role in transcriptional gene silencing in 82 
human cells (Hossain and Stillman, 2016). ORC2 depletion after pre-RC assembly resulted in 83 
spindle and DNA damage checkpoint activation, and impaired sister-chromatid cohesion 84 
(Shimada and Gasser, 2007). In Drosophila, Orc2 mutants showed reduced S phase cells, 85 
increased number of mitotic cells with abnormally condensed chromosomes and chromosome 86 
alignment defects, and more importantly, those mutants could not survive at late larval stage 87 
(Loupart et al., 2000; Pflumm and Botchan, 2001). In human, mutations in ORC1, ORC4, 88 
ORC6, CDT1, and CDC6 are detected in Meier-Gorlin syndrome patients (Bicknell et al., 2011b, 89 
2011a; Guernsey et al., 2011; Hossain and Stillman, 2012; Munnik et al., 2015). ORC1 and 90 
ORC2 localize to centrosomes and ORC1 regulates the re-duplication of the centriole (Hemerly 91 
et al., 2009; Prasanth et al., 2004). ORC also localizes to telomeres via the TRF2 shelterin 92 
protein (Deng et al., 2009; Tatsumi et al., 2008). It was also shown that siRNA knockdown or 93 
CRISPR/Cas9 knockout of ORC1 resulted in loss of MCM2-7 from chromatin, abnormal 94 
duplication of centrioles, and a change in cell cycle stage distribution (Hemerly et al., 2009; Kara 95 
et al., 2015; McKinley and Cheeseman, 2017).  ORC1, ORC2, ORC3, and ORC5 associate with 96 
heterochromatin, and depletion of any ORC subunits disrupt localization of heterochromatin and 97 
also causes abnormal heterochromatin decondensation in cells (Giri et al., 2016; Prasanth et 98 
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted August 6, 2020. ; https://doi.org/10.1101/2020.08.06.240358doi: bioRxiv preprint 
 4 
al., 2010, 2004). ORC2 and ORC3 also specifically localize to centromeric heterochromatin 99 
during late S phase, G2 and mitosis and removal of these proteins causes decondensation of 100 
centromeric a-satellite (Craig et al., 2003; Prasanth et al., 2010, 2004). 101 
There is an emerging debate, however, about the essential nature of ORC in human cells (Bell, 102 
2017). ORC is overexpressed in numerous cancerous cell lines (McNairn and Gilbert, 2005) and 103 
HCT116 colorectal cancer cells can survive with only 10% of the ORC2 protein level (Dhar et 104 
al., 2001). More importantly, it was reported that HCT116 p53-/- (TP53-/-, but we henceforth use 105 
p53-/-) cells in which expression of either ORC1 or ORC2 subunit was eliminated using 106 
CRISPR-Cas9 mediated gene ablation could still proliferate (Shibata et al., 2016). Here we 107 
developed a genetic method to address the function of the pre-RC proteins ORC and CDC6, 108 
particularly focusing on the ORC1 and ORC2 subunits. We demonstrate that ORC proteins are 109 
essential for normal cell proliferation and survival in human cells. Moreover, ORC1 or ORC2 110 
depleted cells showed multiple defects in progression through cell division cycle, including DNA 111 
replication and mitosis, as well as defects in nuclear structure. 112 
Results 113 
ORC1-6 and CDC6 are essential for cell survival 114 
Despite the implication that ORC in performs a critical role in DNA replication as well as cellular 115 
proliferation, there are conflicting observations about the essential role for the ORC1 and ORC2 116 
subunits in human cells (Shibata et al., 2016). To further confound the issue, examination of the 117 
genes essential for cell survival in the DepMap database that summarize results from whole-118 
genome CRISPR screens (GeCKO 19Q1 and Avana 20Q2 libraries) (Meyers et al., 2017; 119 
Tsherniak et al., 2017), show that ORC1 is found to be a common essential gene while ORC2 is 120 
listed as non-essential in tested cell types (Figure 1—Figure supplement 2a). Other members of 121 
the pre-RC proteins - ORC3-6, CDC6, MCM2-7 (data not shown) and CDT1 (data not shown) 122 
are all classified as common essential by at least one of the two whole genome CRISPR 123 
screens (GeCKO and Avana) but not necessarily both in DepMap. 124 
To address the question of essentiality and to map functional domains within the ORC and 125 
CDC6 proteins, we used unbiased tiling-sgRNA CRISPR depletion screens which have been 126 
shown to be informative of not only the overall essentiality of the protein to cell fitness but also 127 
directly help nominate previously unknown, functionally essential regions in these in proteins, 128 
DNA and RNA (He et al., 2019; Hsu et al., 2018; Montalbano et al., 2017; Shi et al., 2015; Wang 129 
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et al., 2019). We employed a tiling sgRNA CRISPR scheme using designed libraries of guide 130 
RNA targeting every possible PAM sequence 5′-NGG-3′ (Streptococcus pyogenes Cas9) across 131 
each exon of ORC1-6 and CDC6. These CRISPR libraries also included control guide RNAs 132 
targeting either known core essential genes or those targeting non-essential gene loci or no loci 133 
at all (Miles et al., 2016). The total library comprised 882 guides targeting ORC1-6 and CDC6, 134 
1602 negative controls (Used in GeCKO V2 library - “NeGeCKO” (Sanjana et al., 2014), 135 
negative controls used in The Sabatini/Lander CRISPR pooled library (Park et al., 2016), 136 
Rosa26, CSHL in-house negatives (Lu et al., 2018; Tarumoto et al., 2018) and 43 positive 137 
controls (median of 3 guides targeting essential genes such as those encoding CDK1, CDK9, 138 
RPL9, PCNA etc.) (Supplement Table1_guides). Parallel screens were done in HCT116-Cas9 139 
and RPE-1-Cas9 cell lines and the relative depletions of guide RNA in the cell populations 140 
between day 3 and day 21 were compared using the guide read counts generated by illumina 141 
based next-generation sequencing (n = 2 for HCT116, n = 1 for RPE-1) and the data was 142 
analyzed with MAGeCK (Li et al., 2014). The screens performed well as shown by the 143 
consistent log fold change (LFC) pattern of depletion or enrichment of positive and negative 144 
controls respectively - although the absolute values and range of LFCs were cell-line specific. 145 
As expected, overall the CRISPR-Cas9 screen had a more profound effect on the diploid RPE-1 146 
cells as compared to a transformed cell line like HCT116. The LFC threshold of ‘essentiality’ 147 
was set at the value at which a guide RNA was depleted more than every negative control as 148 
well as ≥ to the median depletion of guides targeting positive controls (Figure 1—Figure 149 
supplement 1b-d). In two replicate screens of HCT116, LFC ≥ -1 and LFC ≥ -5 in RPE-1, were 150 
found to be the cut-off for log fold depletion, above which the regions of the protein can be 151 
called essential. The fact that many such regions exist across the protein of course also imply 152 
the protein itself is essential to the cell line. Importantly, screens showed significant drop out of 153 
guide RNAs that target regions that have been previously annotated by structure and function 154 
(Figure 1a-b, 1f, Figure 2a-c, Figure 2—Figure supplement 1a, 3a-c, 3g, 4a-c, 4g, 4h-j, 4n, 5a-c, 155 
5g, 5h-j, 5n). To visualize the tiling sgRNA data mapped to translated protein sequence in 156 
relation to its amino acid conservation and disorder we used NCBI RefSeq coding sequences 157 
(NP_004144.2, NP_006181.1, NP_862820.1, NP_859525.1, NP_002544.1, NP_055136.1, 158 
NP_001245.1) for three analyses - (1) FrPred (Adamczak et al., 2004; Fischer et al., 2008) 159 
(https://toolkit.tuebingen.mpg.de/frpred) server that calculates a conservation score based on 160 
amino acid variability as well as the probability of it being a functional ligand binding or catalytic 161 
site at each amino acid position of the input sequence (Figure 1c, Figure 2—Figure supplement 162 
1b, 3d, 4d, 4k, 5d, 5k); (2) Consurf (Ashkenazy et al., 2016) (https://consurf.tau.ac.il/) server 163 
which analyses the probability of structural and functional conservation despite amino acid 164 
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variability for any given position of input sequence (Figure 1d, Figure 2—Figure supplement 1c, 165 
3e, 4e, 4l, 5e, 5l). We ran this server overall with default parameters except for the number of 166 
species to include. In one analysis we chose 50 representative species homologues with 167 
maximum and minimum percent identity set to 95 and 50 respectively, and in the other we 168 
increased the species to 150 and set max. and min. percent identity to 95 and 35 to compare a 169 
larger evolutionary subset. In both analyses the UNIREF90 database was used, which consists 170 
of cluster sequences that have at least 90% sequence identity with each other into a single 171 
UniRef entry, thus increasing the representative diversity of species considered in the output.  172 
And lastly, 3) Disopred tool (Buchan and Jones, 2019; Jones and Cozzetto, 2015) 173 
(http://bioinf.cs.ucl.ac.uk/psipred/) that scores for intrinsically disordered regions (IDRs) that are 174 
usually not well conserved yet found to be functionally essential in many proteins (Figure 1e, 175 
Figure 2—Figure supplement 1d, 3f, 4fm 4m, 5f, 5m). In this similar way, we also performed 176 
tiling sgRNA screens for MCM2-7 and CDT1 and found them to be essential, but including that 177 
data was currently beyond the scope of this work.  178 
For the purpose of this paper, we focus on discussing the tiling-sgRNA screens for ORC1 and 179 
ORC2 and compare the phenotypic differences with DepMap datasets as well as the previous 180 
study that classified these two subunits as non-essential. The pattern of depletion for ORC1 181 
showed that the strongest (higher in the plot) depletions map within the Bromo-Adjacent 182 
Homology (BAH) domain, ATPase Associated with diverse cellular Activities domain (AAA+) 183 
and the Winged-Helix Domain (WHD), all of which are crucial for its function (Figure 1a, 1b, 1f). 184 
The same is evident in both cell lines for ORC2 where the highly depleted guides cluster to the 185 
ATPase-like C terminal end of ORC2 (Figure 2a-c). Interestingly, we found there were 186 
functionally essential regions in the lesser conserved IDR regions of both ORC1 and ORC2. Our 187 
lab has recently reported that a Cyclin-motif bearing region of ORC1 (180 - 240 aa) is essential 188 
for binding to CDC6 at the right time during the cell cycle to enable pre-RC formation (Hossain 189 
et al., 2019). And similarly, based on homology, a previously identified putative NLS motif 190 
(Lidonnici et al., 2004) also had hits nominating that region as essential in our ORC1 screen 191 
(Figure 1f). There are other essential regions that correspond to novel protein binding sites that 192 
are separately being investigated. 193 
When we compared DepMap CRISPR Achilles (Avana 20Q2 library) dataset and a combined 194 
RNAi dataset of cell lines, it indicated that using the CRISPR method, with a gene effect score 195 
of less than -0.5, ORC1 classified as common essential in > 90 percent of the cell lines, while 196 
with RNAi datasets with that same cut-off, it classified as essential in only about 45 percent of 197 
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the same cell lines (Figure 1—Figure supplement 2b-c). It is evident that the method of choice 198 
did have a bearing on the phenotypic outcome of the knock-down. The study by Shibata et al. 199 
(2016) that found ORC1 and ORC2 to be non-essential also used CRISPR editing as the 200 
method of knock-down, but also performed long term selection for cell proliferation to obtain 201 
ORC1-/- of ORC2-/- cells. We therefore determined our screen had guide RNAs that were used in 202 
either of the DepMap dataset or used in the directed study (Shibata et al., 2016). For ORC1 and 203 
ORC2 sgRNAs that were used in DepMap datasets, there was a variation in their phenotype as 204 
measured by LFC values, with some guides classifying ORC1 and ORC2 as essential and 205 
others not (Figure 2—Figure supplement 2a-c). Of note is the fact that the guide used to target 206 
ORC2 in the Shibata et al. (2016) study showed activity very close to the cut-off in HCT116 cells 207 
and scored as non-essential in RPE-1. It is important to note that when a guide targeting a 208 
relatively non-essential region allows for the cells to proliferate, no conclusion can be made 209 
about the protein being essential. The Shibata et al. (2016) study used that single guide to insert 210 
a blasticidin and a poly A cassette into the locus, presumably disrupting its transcription 211 
significantly, while our single-guide-per-locus type of screen did not introduce such large 212 
insertions. We find that ORC1-6, CDC6 are essential in both cell lines tested, and that the 213 
depletion of these proteins negatively affected the diploid RPE-1 cells more. The results of 214 
these screens and the published DepMap conclusions, especially about ORC2, suggest that 215 
using too few guides to target proteins can lead to artifactual observations both in terms of 216 
essentiality or non-essentiality, and that overall gene-effect is affected by the combination of the 217 
choice of guide RNA and the cell line studied. At this point we selected guide RNAs that target 218 
ORC2 from our tiling sgRNA screen to study them individually (Figure 2—Figure supplement 219 
2d). We also received ORC1 and ORC2 deficient stable cell lines from the authors of the 220 
previous study (Shibata et al., 2016) for further analysis. 221 
Rapid ORC2 removal in cancer cells impedes cell growth and causes DNA damage 222 
Depleting ORC2 with an siRNA approach was a slow process that took at least 24-48 hours, 223 
however, using this approach various phenotypes have been observed, including G1 arrest, an 224 
S-phase defect, and abnormally condensed chromosomes as well as defects in mitosis 225 
(Prasanth et al., 2010, 2004). These phenotypes can be an outcome of accumulated errors that 226 
happen during any phase of cell cycle and thus it is hard to distinguish between primary and 227 
secondary phenotypes associated with the loss of ORC2. Therefore, we used CRISPR/Cas9 in 228 
combination with tagging ORC2 with an auxin inducible degron (mAID) to construct cell lines in 229 
which the endogenous ORC2 was knocked out by CRISPR, and the complementing CRISPR-230 
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 8 
resistant mAID-ORC2 could be then rapidly removed from cells, allowing exploration of the 231 
importance of ORC2 at different stages of cell division cycle (Natsume et al., 2016; Nishimura et 232 
al., 2009). To mediate the endogenous ORC2 knockout, four sgRNAs were selected from the 233 
CRISPR screen to validate the screening result. For complementation, mAID-tagged sgRNA 234 
resistant ORC2 (mAID-ORC2gr) was constructed with the mAID degron fused to the ORC2 235 
amino-terminus, and the ORC2 cDNA was edited to harbor multiple mismatches based on two 236 
of the sgRNAs, ORC2-1 and ORC2-2 (Figure 2d). The mAID-ORC2gr was transduced into the 237 
TO-HCT116 cell line, which expresses a doxycycline-inducible Oryza sativa (Asian rice) TIR1 238 
(OsTIR1) gene that encodes a plant auxin-binding receptor that interacts with the conserved E3 239 
ubiquitin ligase SCF complex to degrade mAID-tagged proteins (Natsume et al., 2016; 240 
Nishimura et al., 2009), or the U2OS cell line to perform ORC2 depletion or genetic 241 
complementation, respectively. The effects of four sgRNAs were tested. In the negative-242 
selection CRISPR/Cas9 experiment, cells expressing a positive control RPA3 sgRNA and all 243 
four ORC2 sgRNAs, but not the negative control Neg15 sgRNA, were outcompeted over 3 244 
weeks in culture by non-transduced cells that lacked any sgRNA (Figure 2e-f). The CRISPR 245 
competition effects by ORC2-1 and ORC2-2 sgRNAs were rescued by mAID-ORC2gr in both 246 
TO-HCT116_mAID-ORC2gr and U2OS_mAID-ORC2gr cell lines (Figure 2f-h).  247 
To acquire cloned cells to study ORC2 depletion phenotypes, TO-HCT116_mAID-ORC2gr cells 248 
were depleted of the ORC2 gene with sgRNA ORC2_1 by the CRISPR/Cas9 editing technique 249 
then individual clones isolated after single cell sorting. Five cell lines, ORC2_H-1, ORC2_H-2, 250 
ORC2_H-3, ORC2_H-4, and ORC2_H-5, were obtained from two independent CRISPR/Cas9 251 
knockout experiments done about 6 months apart. Sequencing of the target sites showed that 252 
the ORC2_H-1 and H-3 cell lines had heterozygous mutations at the sgRNA targeting site which 253 
create premature stop codons downstream of the target site (Figure 3—Figure supplement 1a). 254 
On the other hand, H-2, H-4, and H-5 are homozygous with an identical two-nucleotide-deletion, 255 
creating a nonsense mutation at the sgRNA targeting site. Although ORC2_1 sgRNA targets the 256 
C-terminus of ORC2, no truncated form of protein was detected by western blot. Our ORC2 257 
rabbit polyclonal antibody was produced against amino-terminus half of the ORC2 protein. The 258 
LTR-driven mAID-ORC2gr was low in expression compared to expression in the TO-HCT116, 259 
RPE-1 and IMR90 cells, but was sufficient to complement the loss of endogenous ORC2 done 260 
by CRISPR knockout (Figure 3a).  261 
We focused on analysis of the effects of auxin-induced ORC2 depletion in the H-2, H-4, and H-5 262 
cell lines because they have rapid depletion of mAID-ORC2gr after auxin treatment. We 263 
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excluded off target effects by confirming the ORC2-H-2 cloned cell line was resistant to both 264 
ORC2-1 and ORC2-2 sgRNAs, but not to the ORC2-3 and ORC2-4 sgRNAs (Figure 3—Figure 265 
supplement 1b). Compared with the parental TO-HCT116 cell line, the human diploid cell RPE-1 266 
had about 50% of the amount of ORC2, while IMR-90 cells had about 15% (Figure 3a). The 267 
relative levels of ORC3 reflect the levels of ORC2 since they are known to form an intertwined 268 
complex throughout the cell cycle (Dhar et al., 2001; Jaremko et al., 2020; Vashee et al., 2001).  269 
ORC2_H-2, H-4, and H-5 had no endogenous ORC2 detected (note, a nonspecific smaller band 270 
was detected in between the two endogenous ORC2 proteins) (Figure 3a). In addition, 271 
ORC2_H-2 cells expressed mAID-ORC2gr at about 5% compared to endogenous ORC2 level in 272 
TO-HCT116, and H-4 and H-5 cells expressed about 10% of the endogenous ORC2 level. It is 273 
known that cancer cells can proliferate normally with 10% of the levels of ORC2 (Dhar et al., 274 
2001). 275 
Next, we compared the proliferation rates in these cell lines. In normal media conditions the 276 
ORC2_H-4, H-4, and H-5 cells grew only slightly slower than the parental TO-HCT116 cells 277 
(Figure 3b). When doxycycline only was added to induce the OsTIR protein expression, the 278 
proliferation rate of all cell lines decreased, possibly due to some toxicity of doxycycline or the 279 
expression of the OsTIR1 protein itself (Figure 3c). Importantly, the ORC2_H-4, H-4, and H-5 280 
cells proliferated like the parental TO-HCT116 cells. Moreover, auxin alone did not affect the 281 
proliferation rate of wild type TO-HCT116, H-4, and H-5 cells, but it reduced the proliferation 282 
rate of H-2 cells substantially (Figure 3d). This phenotype was probably due to the leaky 283 
expression of Tet-OsTIR1 in the ORC2_H-2 cells. Importantly, when both doxycycline and auxin 284 
were added, all three ORC2 KO cell lines stopped proliferating, whereas the parental TO-285 
HCT116 cells continued to proliferate (Figure 3e).  286 
Concomitant with the lack of cell proliferation, the cell cycle profile changed after mAID-ORC2gr 287 
was depleted in these cells. Cells were treated with doxycycline and auxin to deplete mAID-288 
ORC2gr for 0 hr., 4 hr., 24 hr., and 50 hr. at most. At the 50 hr. time point, all three ORC2 KO 289 
cell lines had less cells progressing from G1 into S phase, and more cells accumulated at the 290 
end of S phase or at the G2/M phase (Figure 3f, Figure 3—Figure supplement 2). Cells with a 291 
4C DNA content (late S/G2/M phase) continued to incorporate EdU suggesting that DNA 292 
replication was not complete, even though the bulk of the genome was duplicated. This 293 
phenotype was consistent with previous observations that cells treated with ORC2 siRNA 294 
arrested in interphase (70%) or as rounded, mitotic-like cells (30%) (Prasanth et al., 2004). 295 
To analyze whether the cell cycle arrest was due to checkpoint activation in response to DNA 296 
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damage, cell extracts were prepared from doxycycline and auxin treated cells and proteins 297 
detected by immunoblotting with various DNA damage markers. CHK1 is essential for the DNA 298 
damage response and the G2/M checkpoint arrest and is primarily phosphorylated by ATR, 299 
while phosphorylation by ATM has also been reported (Gatei et al., 2003; Goto et al., 2019; 300 
Jackson et al., 2000; Liu et al., 2000; Wilsker et al., 2008). ORC3 and mAID-ORC2gr proteins in 301 
ORC2_H-2, H-4, and H-5 cell lines were depleted after 4 hours of auxin treatment, while ORC1 302 
and CDC6 levels remained unchanged (Figure 3g). Phosphorylation of ATM(S1981), 303 
ATR(T1989), and CHK1(S345) was detected in H-2, H-4, and H-5 after 50 hr. of auxin 304 
treatment, but not in the parental TO-HCT116 cells (Figure 3g, Figure 3—Figure supplement 305 
3a). Higher levels of P-gH2AX(S139) in H-2, H-4, and H-5 cells were detected even when no 306 
auxin was added (Figure 3g). This showed that although cells can divide with only 5-10 % of 307 
ORC2, a certain degree of DNA damage existed. In this experiment, the level of 308 
phosphorylated-CHK2(T68) showed no difference between control and mutant cells, but did 309 
increase along with mAID-ORC2gr depletion. Supporting results were also found using 310 
immunofluorescent staining of individual cells. When doxycycline and auxin were added for 48 311 
hours, substantially more ATM(S1981) and CHK1(S345) phosphorylation were detected in all 312 
three ORC2 KO cell lines (Figure 3h-i). In the absence of doxycycline and auxin, the P-313 
gH2AX(S139) signal was more abundant in ORC2_H-2, H-4, and H-5 cells than in wild type 314 
(Figure 3—Figure supplement 3b). To conclude, insufficient ORC2 protein in cells resulted in 315 
abnormal DNA replication and DNA damage, and in response to DNA damage, CHK1 was 316 
activated and cells arrested in G2 phase. 317 
Loss of ORC2 results in heterochromatin decompaction and abnormal nuclear 318 
morphology 319 
The ORC2 depleted ORC2_H-2 and ORC2_H-5 cells had twice the nuclear volume following 320 
treatment with doxycycline and auxin for 48 hr. (Figure 4a-b) compared to cells without 321 
treatment. The volume of the nucleus was greater than the volume of the largest parental cells, 322 
and thus was not due to their arrest with a 4C DNA content. This phenotype could be due to 323 
cells arrest in G2 phase with heterochromatin decompaction, since ORC2 depletion using 324 
siRNA decondenses centromere associated a-satellite DNA (Prasanth et al., 2010). During 325 
interphase, ORC2 and ORC3 localize to the heterochromatin foci and interact with 326 
heterochromatin protein 1a (HP1a) through ORC3 (Prasanth et al., 2004). To detect 327 
heterochromatin decompaction, immunofluorescent staining of the centromeric protein C 328 
(CENP-C) was performed. In TO-HCT116 cells, CENP-C staining showed multiple, compact 329 
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foci, but in the doxycycline and auxin treated cells that were dependent on mAID-ORC2gr, 330 
CENP-C foci were larger and more prominent (Figure 4c). These observations were consistent 331 
with heterochromatin decompaction in ORC2 depleted cells.  332 
ORC2 is essential for initiation of DNA replication 333 
When cells were treated with siRNA against ORC2 for 72 hours, 30% of the cells arrested in a 334 
mitosis-like state (Prasanth et al., 2004). This observation led to the conclusion that ORC2 is not 335 
only required for the initiation of DNA replication, but also during mitosis. To examine the role of 336 
ORC2 in G1 and mitosis following acute depletion, TO-HCT116 and the ORC2_H-2 cells were 337 
synchronized at the G1/S phase boundary with a 2C DNA content with a double thymidine 338 
block, with doxycycline added during the second thymidine block. When indicated, auxin was 339 
added 4.5 hours before the release from the second thymidine block and the cells followed for 340 
progression through two cell division cycles (Figure 5a). Cells were harvested at several 341 
timepoints after release and pulse-labeled with EdU for two hours. During the first cell cycle 342 
following release into S phase, no obvious change in DNA content and EdU labeling was 343 
observed, whether doxycycline and auxin was added or not (Figure 5b-c; Figure 5—Figure 344 
supplement 1). During the second cell cycle, however, doxycycline and auxin-treated TO-345 
HCT116 cells progressed through S phase only slightly slower than the untreated cells. In 346 
contrast, serious cell cycle defects were observed between the ORC2_H-2 auxin-treated or 347 
untreated cells, starting with the second cell cycle (Figure 5b-c). First, auxin treated ORC2_H-2 348 
cells exhibited a very slow S phase, indicating that cells were struggling to correctly replicate the 349 
DNA. Second, cells arrested with a 4C DNA content, which could be in the stage of late S or 350 
G2/M phase. Thirdly, after 48 hours of releasing from the double thymidine block, some cells 351 
were arrested in G1 phase and couldn’t enter S phase. Since auxin was added 4.5 hours before 352 
second thymidine release and it required about 4 hours to knockdown mAID-ORC2gr, those 353 
phenotypes were observed only during the second cell cycle, suggesting that, for the first cell 354 
cycle, the pre-RC was already formed and the cells were primed to replicate the complete 355 
genome. ORC2 depleted cells then either arrested during G1 or went through an incomplete S 356 
phase and arrested at the G2/M phase and did not progress further. This experiment indicated 357 
ORC2 primarily functions in establishing DNA replication initiation, as expected, but based on 358 
the results so far, we could not conclude a role during mitosis because most ORC2 depleted 359 
cells with a 4C DNA content continued to replicate DNA. 360 
An MCM complex loading and pre-RC assembly defect in ORC2 depleted cells 361 
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The auxin-treated, mAID-ORC2gr depleted cells could not replicate normally, possibly due to 362 
insufficient ORC to form the pre-RC. To test this hypothesis, the DNA-loaded MCM2-7 was 363 
measured by extracting the asynchronous cells with detergent and examining the chromatin 364 
bound MCM2 in relation to cell cycle stage using flow cytometry, as described previously 365 
(Matson et al., 2017). Asynchronous TO-HCT116, ORC2_H-2, and H-5 cells with or without 366 
doxycycline and auxin treatment were pulse-labeled with EdU, harvested and stained with anti-367 
MCM2 antibody and DNA dye. The results showed that in normal media without detergent 368 
extraction, nearly 100% of the cells were positive for MCM2 in all three cell lines (Figure 6a; 369 
Figure 6 –Supplement 1). When extracted, about 78 % of TO-HCT116, 65.2 % of ORC2_H-2, 370 
and 76.9 % of ORC2_H-5 cells were positive for MCM2. When cells were treated with both 371 
doxycycline and auxin for 20 hours, 84.5 % of TO-HCT116 cells had DNA-loaded MCM2, while 372 
only 4.42% of H-2 and 26.2% of H-5 cells did (Figure 6b; Figure 6—Figure supplement 1). The 373 
different degrees of reduced MCM2 between H-2 and H-5 was expected because the level of 374 
mAID-ORC2gr in H-2 was only half the amount compared to H-5 cells, and auxin knockdown 375 
was not 100% efficient. Of particular importance was the lack of MCM2 on chromatin in the G1 376 
phase cells when mAID-ORC2gr was depleted. In conclusion, low number of pre-RC formation 377 
on DNA origins results in cells arresting in G1. Those cells that still initiated DNA replication 378 
have a very slow S phase and arrested at G2/M with DNA damage and checkpoint activation. 379 
ORC2 depletion in cells leads to aberrant mitosis 380 
In order to know if the mAID-ORC2gr depleted cells entered mitosis, we evaluated the mitotic 381 
index by staining cells with anti-pH3S10 and followed by flow cytometry analysis. In a normal 382 
asynchronous cell population, about 4.53 ± 0.59 % and 1.57 ± 0.33 % were pH3S10-positive in 383 
TO-HCT116 and ORC2_H-2 cells respectively, while 31.4 ± 2.88 % of TO-HCT116 cells and 384 
15.6 ± 1.25 % of ORC2_H-2 cells were at G2/M (Figure 7a; Figure 7—Figure supplement 1). 385 
When only doxycycline was added, there was no significant change. When treated with 386 
doxycycline and auxin for 28 hours, the pH3S10-positive cell population percentage was about 387 
2.39± 0.26 in TO-HCT116 and only 0.79 ± 0.09 in ORC2_H-2, while 17.23 ± 0.78 % of TO-388 
HCT116 cells and 36.7 ± 1.61 % of ORC2_H-2 cells were at G2/M. After 50 hr. dox and auxin 389 
treatment, the pH3S10-positive cell population percentage was 3.95 ± 0.16 in TO-HCT116 and 390 
only 0.96 ± 0.15 in ORC2_H-2, while 20.77 ± 1.76 % of TO-HCT116 cells and 79.57 ± 1.2 % of 391 
ORC2_H-2 cells were at G2/M phase. In normal media conditions, TO-HCT116 already had 2.9 392 
times as many mitotic cells as ORC2_H-2. When treated with doxycycline and auxin, although 393 
the G2/M population increased 2.3- fold and 5- fold at 28 hr. and 50 hr., respectively, the 394 
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number of mitotic cells in ORC2_H-2 was reduced 50 - 80 % compared to the non-treated H-2 395 
cells. This showed that most ORC2_H-2 cells accumulated at the 4C DNA peak after ORC2 396 
depletion were in the G2 stage and most cells did not enter into mitosis. 397 
Nevertheless, mitosis still occurred at a very low frequency. To observe how mitosis progression 398 
was affected after ORC2 depletion, we constitutively-expressed H2B-mCherry in TO-HCT116 399 
and ORC2_H-2 cells via lentiviral transduction and performed time lapse fluorescent imaging of 400 
the mitotic chromosomes. Cells were synchronized using a single thymidine block and auxin 401 
was added or omitted 2 hours before releasing into fresh media with or without doxycycline and 402 
auxin. As expected, the first cell cycle after releasing from the thymidine block in both cell lines 403 
with or without doxycycline and auxin was normal and cells that progressed into mitosis and into 404 
the second cell cycle. During the second cell cycle, in the absence or presence of doxycycline 405 
and auxin, it took TO-HCT116 cells about 35 min. to progress from prophase to chromosome 406 
segregation (Figure 7b and c). The ORC2_H-2 cells in the absence of doxycycline and auxin 407 
also progressed thought mitosis like the parental cells (Figure 7d). In stark contrast, the 408 
ORC2_H-2 cells in the presence of doxycycline and auxin condensed chromatin and attempted 409 
to congress chromosomes at the metaphase plate but never achieved a correct metaphase 410 
alignment of chromosomes even after seven hours (Figure 7e). Those few cells that did attempt 411 
anaphase had abnormal chromosome segregation, producing lagging chromosomes, 412 
micronuclei and eventually apoptosis. 413 
Characterization of previously published ORC1-/- and ORC2-/- cell lines 414 
The results so far confirm previous observations that ORC is essential for cell proliferation in 415 
human cells, but there remains the curious case of the viable knockout of ORC1 and ORC2 416 
genes in p53-/- HCT116 cells which needs to be explained (Shibata et al., 2016). We obtained 417 
two of the ORC1-/- and ORC2-/- cell lines used in that study and performed several experiments. 418 
We first tested whether using CRISPR/Cas9 to target ORC2 with sgRNAs in the ORC2-/- cell 419 
line, whether negative selection occurred like that in the wild type HCT116 cells as shown in 420 
(Figure 2e). The sgRNA target GFP competition assay showed that in both parental HCT116 421 
p53-/- and ORC2-/- cell lines, cells targeted with ORC2 sgRNA were outgrown by sgRNA-422 
negative cells (Figure 8a-b). More importantly, both cell lines expressing mAID-ORC2gr rescued 423 
or partially rescued the sgRNA targeting effect with a mAID-ORC2gr that was resistant to the 424 
ORC2-1 and ORC2-2 sgRNAs, showing that the depletion was not due to an off-target effect of 425 
the ORC2 sgRNAs (Figure 8c-d). This assay suggested that there is some form of functional 426 
ORC2 in the ORC2-/- cells that could be targeted by the tested sgRNAs. In addition, an 427 
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immunoblot of the cell lysates showed a reduced level of ORC3 in the ORC2-/- cells, and since 428 
ORC2 and ORC3 form stable heterodimers in cells, this result again indicated that some form of 429 
ORC2 was expressed in cells, albeit at a lower level (Figure 8—Figure supplement 1a). When 430 
immunoprecipitated with an antibody against ORC3, we detected ORC3 and a putative 431 
truncated form of ORC2 which was seen only in ORC2-/- cells (Figure 8—Figure supplement 432 
1b). Next, we designed primer pairs that span the exon junction for every exon in ORC2 and 433 
performed quantitative RT-PCR (qPCR) to determine the nature of the ORC2 transcripts in the 434 
ORC2-/- cells (Figure 8e). The fold change (FC) indicated that in ORC2-/- cells, about 60% of the 435 
mRNAs had exon 7 skipped, whereas other exons remained the same (Figure 8—Figure 436 
supplement 2).  437 
With the idea that genomic instability caused by the absence of or mutation within either ORC1 438 
or ORC2 in these cell lines might give rise to copy number variations, we performed SMASH 439 
(Wang et al., 2016) analysis on the two parental HCT116 with the p53 WT and p53 null 440 
background as well as the Shibata et al. (2016) ORC1 and ORC2 deficient lines. Both the 441 
parental cell HCT116 cell lines showed very similar chromosome copy number, while both 442 
ORC1 deficient and ORC2 deficient cell lines had additional CNVs in chromosomes unrelated to 443 
those harboring either ORC1 or ORC2 (Figure 8—Figure supplement 3).  The significance of 444 
these specific loci which showed alterations in copy number when either ORC1 or ORC2 was 445 
deleted remains to be seen. However, it was in this analysis that we also noticed that part of the 446 
ORC2 gene locus was hugely amplified (Figure 8—Figure supplement 3 solid arrow). To study 447 
in detail the ORC2 gene region on chromosome 2 in the putative ORC2-/- cells, we performed 448 
long-read Nanopore sequencing analysis that showed the ORC2 gene in ORC2-/- cells was 449 
highly rearranged and heterogenous (Figure 8f). Aside from the aforementioned heterozygous 450 
deletion of the 7th exon, the region near the 3rd and 4th exons also exhibited overwhelming 451 
amplification and structural rearrangement signatures (Figure 8f). Thus, the ORC2 gene is 452 
present but has heterogenous expression of exon 7 and is sensitive to sgRNAs that target 453 
ORC2. We conclude that the cell line is not a true ORC2 knockout. 454 
With regard to the HCT116 ORC1-/- (B14) cell line, we confirmed that they lacked ORC1 protein 455 
using multiple antibodies and confirmed that they duplicated at a much slower rate than the 456 
parental line, as previously reported (Shibata et al., 2016). Furthermore, we were unable to 457 
passage these cells for many generations (by 30 generations they stopped proliferating). We 458 
also compared HCT116 ORC1-/- (B14) and HCT116 ORC2-/- (P44) cell lines with the parental 459 
lines, both either p53 WT or null background by confocal microscopy [Figure 8g (1-4), 8h; Figure 460 
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8—Figure supplement 4a-e, Figure supplement 5a-c]. There was a myriad of nuclear 461 
morphology defects in the ORC1 deficient cell line. When the nuclei were stained with Hoechst 462 
dye, up to 10 percent contained abnormally large nuclei or sometimes what seemed to be 463 
multiple nuclei aggregated together in single cell, while many other of the cells appeared 464 
normal. When probed further by staining for F-actin and Lamin B1 for overall cellular and 465 
morphology and nuclear membrane integrity respectively, we saw that despite the staining for 466 
DNA content looking normal, up to 50 percent of the ORC1-/- cells showed highly abnormal, 467 
involuted nuclear membranes (Figure 8i). In addition, most of the gigantic nuclei seemed to 468 
have lost the nuclear membrane, while those cells that had Lamin B1 staining displayed 469 
abnormal nuclear membrane integrity. 470 
The chromatin organization in the ORC1 deficient cells was observed by transmission electron 471 
microscopy (TEM) and revealed a huge difference in cell size and nuclear structure between the 472 
wild type HCT116 p53+/+ and ORC1-/- (Figure 8—Figure supplement 5). About 35 % of ORC1-/- 473 
cells were grossly larger than wild type cells. Those multinucleate/polyploid giant cells were full 474 
of membrane invagination, vacuoles and apoptosis. Most likely they were formed due to 475 
extensive DNA damage and nuclear structural defects and underwent a different type of cell 476 
division called neosis, in which intracellular cytokinesis occurs and some mononuclear cells are 477 
produced from nuclear budding or asymmetric cell division (Sundaram et al., 2004).  All those 478 
phenotypes pointed to the fact that although ORC1-/- cells do not survive in culture in the long 479 
term and even when they were slowly proliferating, they were grossly abnormal. It may well be 480 
the case that the p53-/- status was required for these cells to be produced in the first place. 481 
Discussion 482 
The ORC2-/- cell line believed to be a complete knockout via the use of 3 sgRNAs, one targeting 483 
the exon 4, and the others targeting the 6th and 7th introns retained a truncated form of ORC2 that 484 
could interact with ORC3 and was expressed from a rearranged gene. These cells were still 485 
susceptible to ORC2 knockdown using four sgRNAs selected from our CRISPR screens and also 486 
partially rescued the phenotype with of two sgRNAs using a CRISPR-sgRNA resistant mAID-487 
ORC2gr. Similar to what we found for ORC2-/- cells, CRISPR-induced frameshifts in cells often 488 
generate truncated proteins that, although they may not be recognized by western blot, still 489 
preserve whole or partial protein function (Smits et al., 2019). Based on these observations with 490 
ORC2 and the results with ORC1 deficient cells, that despite the over-production of CDC6, were 491 
unable to proliferate for many generations and produced abnormally structured cells, as well as 492 
data analyzed by tiling-sgRNA CRISPR screens, we conclude that ORC is essential in human 493 
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cells. This conclusion is consistent with existing literature (Hemerly et al., 2009; McKinley and 494 
Cheeseman, 2017; Ohta et al., 2003; Prasanth et al., 2010, 2004, 2002) and is not surprising 495 
since ORC has multiple functions in human cells and ORC is essential in all other eukaryotic cells 496 
examined. 497 
The pooled CRISPR/Cas9 domain-focused screen has become a common and powerful tool for 498 
uncovering genes that are essential for cell proliferation, cell survival, and for identification of 499 
essential functional domains in proteins (Adelmann et al., 2018; Park et al., 2016; Shi et al., 2015; 500 
So et al., 2019). However, if the screens use only a handful of guides targeting annotated essential 501 
regions, it may still result in data which may or may not score a gene as essential. Tiling-sgRNA 502 
CRISPR-Cas9 screens on the other hand test ‘functional’ or ‘essential’ domains in a more 503 
unbiased way. Using this approach targeting sgRNAs across entire open reading frames of 504 
ORC1-6 and CDC6 enabled us to classify them as essential, and correlate functional domains 505 
within these proteins. The combined results also confirmed that all ORC1-6 and CDC6 proteins 506 
were essential in cancer cells as well as a human diploid cell line, including ORC2 that was 507 
characterized in the DepMap portal (https://depmap.org/portal/) as non-essential based on 508 
multiple shRNA and whole genome CRIPSR-Cas-9 screens in multiple cells. We were able to 509 
identify many sgRNAs that targeted ORC2 in the tiling-sgRNA CRISPR screen and the two 510 
chosen cloned sgRNAs that killed cells were successfully complemented using a mAID-ORC2gr 511 
transgene, demonstrating specificity of the knockdowns. Thus, large scale experiments, 512 
especially negative results, should be interpreted with caution, such that the essential nature of a 513 
gene should be examined in depth as we have done here. 514 
The known functional domains in ORC1, including the BAH, AAA+ and WHD were identified using 515 
the open reading frame tiling CRISPR-Ca9 sgRNA screen, as well as other regions of ORC1, 516 
including the intrinsically disordered region (IDR; amino acids 180-480, Figure 1e) which we know 517 
binds Cyclins E and A-CDK2 and CDC6 (Hossain et al., 2019) as well as many other proteins we 518 
have identified and are characterizing in detail. The screen also identified an essential region of 519 
ORC1 in and around amino acid 750-790 (Figure 1a-b) which may represent the pericentrin-520 
AKAP450 centrosomal targeting (PACT) domain that localizes ORC1 to centrosomes to regulate 521 
correctly centrosome and centriole copy number (Hemerly et al., 2009). 522 
In ORC2, multiple, essential domains were identified, including the AAA+-like domain and the 523 
WHD. The WHD of human ORC2 controls access of human ORC to DNA by inserting itself into 524 
the DNA binding channel prior to activation of the protein by binding of ORC1 and subsequent 525 
binding of CDC6 (Hossain et al., 2019; Jaremko et al., 2020). The ORC2-carboxy terminus binds 526 
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to ORC3 and ORC2 is also known to bind to PLK1, the mitotic protein kinase (Song et al., 2011). 527 
Interestingly, ORC2 also has an IDR (Figure 2—Figure supplement 1d; amino acids 30-230) and 528 
a gRNA tiling screen of this region shows limited essential amino acids, but a conserved region 529 
surrounding amino acid 190 is reproducibly essential in both HCT116 cancer cells and diploid 530 
(Figure 2a-b and Figure 2—Figure supplement 1a). The entire IDR, however, may contribute to 531 
DNA mediated ORC liquid phase transition (Parker et al., 2019). 532 
The use of a mAID-ORC2gr enabled rapid removal of ORC2 from cells and analysis of the resulting 533 
phenotypes. It was not surprising that ORC2 is essential for loading MCM2 ,and hence MCM2-7, 534 
to establish pre-RCs and origins of DNA replication across the genome. In the absence of ORC2, 535 
cells loaded little MCM2, most likely resulting in too few origins of replication and a consequent 536 
slow S phase and arrest with a near 4C DNA content and ongoing DNA synthesis. ORC2 537 
depletion yielded other phenotypes, including large nuclei and a failure to execute mitosis. The 538 
large nuclei, also observed in the ORC1-/- cells, have large CENP-C foci, probably due to 539 
decompaction of the centromeric associated a-satellite DNA, as observed previously (Prasanth 540 
et al., 2010). We suggest a general role for ORC in nuclear organization and organizing chromatin 541 
domains in the nucleus, including heterochromatin. In yeast, ORC is essential for transcriptional 542 
silencing at the silent mating type heterochromatic loci HMRa and HMLa loci and its function in 543 
replication are separable from that in silencing (Bell et al., 1993; DeBeer et al., 2003; Ehrenhofer-544 
Murray et al., 1995). In Drosophila, ORC localizes and associates with heterochromatin protein 545 
HP1 during interphase and mitosis and heterozygous, recessive lethal mutations in DmORC2 546 
suppress position effect variegation (Huang et al., 1998; Pak et al., 1997). In human, ORC1 547 
interacts with RB and SUV39H1, a histone methyltransferase that tri-methylates histone H3K9 548 
which HP1 binds to repress E2F1-dependent CCNE1 transcription (Hossain and Stillman, 2016) . 549 
ORC1 and ORC3 (a tight ORC2 binding partner) directly interact with HP1, and depletion of ORC 550 
subunits disrupt localization of HP1 and the compaction of chromosome 9 a-satellite repeats DNA 551 
(Prasanth et al., 2010). The mechanism by which the nuclei become large as a result of ORC 552 
depletion is under further investigation. 553 
A final phenotype we observed in the acute removal of ORC2 is that the cells that replicate DNA 554 
and enter into mitosis attempt chromosome congression at the metaphase plate, but never make 555 
it, even after 7 hours. Eventually the cells die of apoptosis. We had observed abnormal mitotic 556 
cells following long term (72 hr.) treatment of cells with shRNAs that targeted ORC2 but it was 557 
not clear if this phonotype was due to incomplete DNA replication (Prasanth et al., 2004). However, 558 
in the current study, acute removal of ORC2 captured some cells with a clear defect in 559 
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chromosome congression during mitosis. Moreover, both ORC2 and ORC3 localize to 560 
centromeres (Craig et al., 2003; Prasanth et al., 2004), suggesting that they play a role in spindle 561 
attachment or centromeric DNA organization, particularly the centromere associated satellite 562 
repeat sequences. We speculate that in ancestral species, ORC localized at origins of DNA 563 
replication and this ORC also functioned in organization of chromosomes and in chromosome 564 
segregation, but upon separation of DNA replication and chromosome segregation with the 565 
advent of mitosis, separate functions of ORC in DNA replication, chromatin or nuclear 566 
organization and chromosome segregation were retained, but executed at different times during 567 
the cell division cycle. 568 
Materials and methods 569 
Cell Culture 570 
HCT116 (WT cell lines is p53+/+), U2OS, and RPE1 cell lines were obtained from the Cold 571 
Spring Harbor Laboratory and cultured in DMEM (Gibco) and supplemented with 10% Fetal 572 
bovine serum and 1 % Penicillin/Streptomycin. IMR-90 cell line is culture in EMEM with 10 % 573 
Fetal bovine serum and 1 % Penicillin/Streptomycin. Plat-E cells and HEK293T cells were 574 
cultured in DMEM supplemented with 10 % FBS and penicillin/streptomycin. Plat-E cells were 575 
used for retroviral production and HEK293T cells were used for lentiviral production. HCT116 576 
(p53-/-), HCT116 ORC1-/- (p53-/- background, clone B14), HCT116 ORC2-/- (p53-/- background, 577 
clone P44) were a kind gift from Dr. Anindya Dutta (University of Virginia, Charlottesville, VA, 578 
USA). Tet-OsTIR1 HCT116 (TO-HCT116) cell line was a kind gift from Dr. Masato Kanemaki 579 
(National Institute of Genetics, Mishima, Japan). All gifted cell lines were cultured in McCoys 5A 580 
(Gibco) supplemented with 10 % fetal bovine serum and 1% Penicillin/Streptomycin. All cell 581 
lines were cultured at 37 °C with 5 % CO2. All of the cell lines used in this study were tested for 582 
mycoplasma and were negative. 583 
 584 
Tiling-sgRNA guide design  585 
Every possible guide directly upstream of a sp-Cas9 canonical PAM (NGG) sequence in the 5’-586 
>3’ direction is extracted from the target exon sequences.  Guides with the canonical PAM 587 
(NGG) are aligned to the hg38 genome using the BatMis exact k-mismatch aligner (Tennakoon 588 
et al., 2012).  A maximum of three mismatches are considered for off-target evaluation.  The 589 
resulting alignment file is parsed, and each off-target location is assessed a penalty according to 590 
the number of mismatches to the target sequence, the exact position of each mismatch in the 591 
guide, where the further the mismatch is from the PAM the higher the penalty, the proximity of 592 
the mismatches to each other; assigning higher penalties to mismatches that are further apart. 593 
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 594 
The resulting penalties from each assessed off-target site are then combined in to a single off-595 
target score for each guide similar to (Hsu et al., 2013), with 1.00 as the maximum possible 596 
score for guides not having any off-target site with up to three mismatches.  The final results 597 
include the guide sequence, the PAM, the number of off-target sites in the genome with 0, 1, 2 598 
and 3 mismatches, the cut site location, the calculated off-target score, and any yes 599 
(Supplement Table 1_guides). 600 
 601 
Plasmid construction and sgRNA cloning 602 
Clonal HCT116-Cas9 expressing cell lines were a gift from Dr. Chris Vakoc and RPE1-Cas9 603 
expressing cell lines were derived from Dr. Jason Sheltzer (Cold Spring Harbor Laboratory, NY, 604 
USA). In this study, all the sgRNAs targeting genes of interest as well as controls were cloned 605 
into LRG2.1 (derived from U6-sgRNA-GFP, Addgene: 108098 - as described in ref (Tarumoto et 606 
al., 2018)). Single sgRNAs were cloned by annealing sense and anti-sense DNA oligos followed 607 
by T4 DNA ligation into a BsmB1digested LRG2.1 vector. To improve U6 promoter transcription 608 
efficiency, an additional 5’ G nucleotide was added to all sgRNA oligo designs that did not 609 
already start with a 5’ G. Sequences of all arrayed sgRNA libraries used in this study are 610 
provided in (Supplement Table1_guides)  611 
 612 
For an unbiased tiling CRISPR domain screen, pooled sgRNA libraries were constructed. All 613 
possible sgRNAs (PAM - NGG) were designed across each exon of the 7 target genes. 614 
Targeting or positive/negative control sgRNAs were synthesized in duplicate or triplicate in a 615 
pooled format on an array platform (Twist Bioscience) and then PCR cloned into the Bsmb1-616 
digested LRG2.1 vector using Gibson Assembly. To ensure the representation and identity of 617 
sgRNA in the pooled lentiviral libraries, a deep-sequencing analysis was performed on a MiSeq 618 
instrument (Illumina) and verified that 100 % of the designed sgRNAs were cloned in the 619 
LRG2.1 vector and that the abundance of >95 % of the sgRNA constructs was within 5-fold of 620 
the mean. While this was as a means to QC for ORC1-6 and CDC6 libraries, for time 621 
considerations, in case of MCM2-7, CDT1 and Control libraries, presence of all guides in the 622 
T=0 sampling during the pooled CRISPR screening (described later) served as a similar QC. 623 
 624 
For CRISPR complementation assays, ORC2 sgRNA resistant synonymous mutations were 625 
introduced to ORC2 by PCR mutagenesis using Phusion high fidelity DNA polymerase (NEB). 626 
Guide RNA resistant ORC2 (ORC2gr) was amplified by PCR and cloned into NheI-digested 627 
mAID-mCherry2-NeoR plasmid (mAID-mCherry2-NeoR, Addgene 72830) in order to add mAID 628 
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degron sequence to the N-terminus. The mAID-ORC2gr was then PCR and assembled into 629 
BglII/XhoI digested pMSCV-hygro retroviral vector (TaKaRa #634401). All cloning was done 630 
using In-Fusion cloning system (TaKaRa). In this experiment, sgRNAs targeting ORC2 and 631 
control sgRNAs were cloned into BsmB1digested LgCG_cc88 lentiviral vector by the same 632 
sgRNA cloning strategy described above.  633 
 634 
For knocking out endogenous ORC2 in TO-HCT116 cells, we used sgRNA_ORC2-1-epCas9-635 
1.1-mCherry plasmid to perform CRISPR/Cas9 in the cells. Sequence of sgRNA_ORC2-1 was 636 
cloned into epCas9-1.1-mCherry plasmid which was a kind gift from Dr. David Spector (Cold 637 
Spring Harbor Laboratory, NY, USA). Single sgRNA were cloned by annealing sense and anti-638 
sense DNA oligos followed by T4 DNA ligation into a BbsI -digested sgRNA_ sgRNA_ORC2-1-639 
epCas9-1.1-mCherry vector.  640 
 641 
To construct lentiviral vector that constitutively express H2B-mCherry in TO-HCT116 and 642 
ORC2_H-2 cells, H2B-mCherry sequence were PCR and cloned into BamHI/BspDI -digested 643 
pHAGE-CMV-MCS-IZsGreen vector which was a kind gift from Dr. Alea Mills (Cold Spring 644 
Harbor Laboratory, NY, USA). 645 
 646 
Viral Transductions 647 
Lentivirus was produced in HEK293T cells by co-transfecting target plasmid and helper 648 
packaging plasmids psPAX2 and pVSVG with polyethylenimine (PEI 25000, cat#) transfection 649 
reagent. HEK293T cells were plated a day before to achieve 80 % - 90 % confluency on the day 650 
of transfection. Plasmids were mixed in the ratio of 1:1.5:2 of psPAX2, pVSVG and target 651 
plasmid DNA in OptiMEM (Cat#). 32 µl of 1 mg/mL PEI (calculated based on the final volume of 652 
transfection) was added, mixed and incubated, before addition to the cells. Cell culture medium 653 
was changed 7 h after transfection, then supernatant collected at 36 and 72 h following 654 
transfection was pooled. For the high throughput lentiviral screening, virus supernatant was 655 
concentrated with Lenti-X™ Concentrator (Takara, #631231) as per the manufacturer's 656 
protocol. 657 
Retrovirus was produced in Plat-E cells by co-transfecting target plasmid and packaging 658 
plasmids pCL-Eco and pVSVG in the ratio of 1.25:1:9 with PEI. Cell culture medium was 659 
changed 7 h after transfection, and the supernatant was collected at 36 hr. post-transfection. 660 
 661 
For either lenti- or retroviral transductions, target cells were mixed with viral supernatant, 662 
supplemented with 8 µg/mL polybrene and centrifuged at 1700 rpm for 30 min. at room 663 
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted August 6, 2020. ; https://doi.org/10.1101/2020.08.06.240358doi: bioRxiv preprint 
 21 
temperature. Fresh medium was replaced 24 h after transduction. Antibiotics (1 µg/mL 664 
puromycin; 10 µg/mL of blasticidin; 200 μg/ml of hygromycin) were added 72 h after infection 665 
when selection was required. 666 
 667 
Pooled sgRNA screening  668 
CRISPR-based negative selection screenings using sgRNA libraries targeting proteins ORC1-6, 669 
CDC6 as well as positive and negative controls, were performed in stable Cas9 expressing 670 
HCT116 and RPE1 cell lines. The screens were performed as previously described (Lu et al., 671 
2018; Miles et al., 2016; Shi et al., 2015) with a few optimizations for scale. Briefly, to ensure a 672 
single copy sgRNA transduction per cell, multiplicity of infection (MOI) was set to 0.3-0.35. To 673 
achieve the desired representation of each sgRNAs during the screen, the total number of cells 674 
infected was determined such that while maintaining the MOI at ~0.3, the sgRNA positive cells 675 
were at least 2000 times the sgRNA number in the library. Cells were harvested at day 3 post-676 
infection and served as the initial time-point (T=0) of the pooled sgRNA library, representing all 677 
guides transduced to begin with. Cells were cultured for 10 population doublings (T=10) and 678 
harvested as the final time point. All experiments were performed in triplicates. Genomic DNA 679 
was extracted using QIAamp DNA midi kit (QIAGEN) according to the manufacturer’s protocol. 680 
 681 
Next Generation Sequencing library was constructed based on a newly developed protocol. To 682 
quantify the sgRNA abundance of initial and final time-points, the sgRNA cassette was PCR 683 
amplified from genomic DNA using Amplitaq Gold DNA Polymerase (Invitrogen, 4311820) and 684 
primers (F2: TCTTGTGGAAAGGACGAAACACCG; R2: TCTACTATTCTTTCCCCTGCACTGT).  685 
The resulting DNA fragment (~ 242 bp) was gel purified. In a 2nd PCR reaction illumina-686 
compatible P7 and custom stacked barcodes (Supplement Table 2_BClist) including the 687 
standard illumina P5 forward primer were introduced into samples by PCR amplification and gel 688 
purified for the final product (~180-200 bp). The final product was quantified by Agilent 689 
Bioanalyzer DNA High-sensitivity Assay (Agilent 5067-4626) and pooled together in equal molar 690 
ratio and analyzed by NGS. A 5% PhiX spike in used was for quality purposes. Illumina libraries 691 
were either sequenced with a 300cycle MiSeqv2 kit or a 76 cycle NextSeq 500/550 kit by single-692 
end sequencing using NextSeq mid-output. (DRYAD doi to be generated) 693 
 694 
Quantification and analysis of screen data: 695 
The quantification of guides was done using a strict exact match to the forward primer, sample 696 
barcode, and guide sequence. MAGeCK was used for the identification of essential sgRNAs by 697 
running the “mageck test” command on the raw sgRNA counts.  MAGeCK employs median 698 
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted August 6, 2020. ; https://doi.org/10.1101/2020.08.06.240358doi: bioRxiv preprint 
 22 
normalization followed by a Negative Binomial modeling of the counts, and provides the log fold 699 
change (lfc) and p-values at both the guide and gene levels (Li et al., 2014). 700 
 701 
GFP competition and sgRNA complementation assay  702 
TO-HCT116, TO-HCT116_mAID-ORC2gr, U2OS, U2OS_mAID-ORC2gr, HCT116 p53-/-, 703 
HCT116 p53-/-_mAID-ORC2gr, ORC2-/- p44, and ORC2 p44-/-_ mAID-ORC2gr cells were 704 
transduced with different sgRNA-Cas9-GFP lentivirus respectively with the MOI at 0.3-0.4 to 705 
ensure one copy of sgRNA transduction per cell. Cells were passaged every 3 days from day 3 706 
(P1) post-transduction to day 21(P7), and at the same time, GFP percentage were evaluated by 707 
guava easyCyte™ flow cytometer. Three technical repeats were done for each datapoint. GFP 708 
percentage of day 3 (P1) for each sgRNA was normalized to 100 %, and then result of each 709 
passage was normalized to day 3 correspondingly. All experiments were repeated twice at 710 
least. 711 
 712 
Generating endogenous ORC2 KO mAID-ORC2gr cell lines 713 
TO-HCT116 cells were transduced with mAID-ORC2gr via retroviral transduction and selected 714 
with 200 μg/ml of hygromycin to grow TO-HCT116-mAID-ORC2gr cells. sgRNA_ORC2-1-715 
epCas9-1.1-mCherry plasmid was transiently transfected into TO-HCT116-mAID-ORC2gr cells 716 
using Lipofectamine 2000 Transfection Reagent (ThermoFisher #11668019) following 717 
manufacturer’s protocol. Fresh medium was replaced 6 h after transfection. Cells were harvest 718 
by 0.25% trypsin-EDTA after 24 hr., washed once with PBS, and then resuspended in sorting 719 
buffer containing 2% FBS, 2 mM EDTA, and 25mM HEPES pH7.0. Single Cell was FACS 720 
sorted by gating on mCherry fluorescence intensity into 96-well plates with 200 μl fresh medium 721 
containing 200 μg/ml of hygromycin. Single cell clone was expanded by transferring to 24-well 722 
plate, 6-well plate, and 10 cm culture dish once they reached 90% confluency. 723 
 724 
Cell Proliferation assays 725 
TO-HCT116, ORC2_H-2, ORC2_H-4, and ORC2_H-5 were treated with or without 0.75µg/ml 726 
doxycycline for 24 hours before seeding. For each cell line, 150,000 cells were seeded in each 727 
well at day 1, and medium was changed every day. Every day we harvested 3 wells for each 728 
cell lines for counting. Cells were stained with 0.4 % trypan blue solution and live cells were 729 
counted by automated cell counter. 730 
 731 
Immunoprecipitation, Immunoblotting and quantitation 732 
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Cells were incubated with RIPA buffer (150 mM NaCl, 1 % NP-40, 0.5 % Sodium deoxycholate, 733 
0.1 % SDS, 25 mM Tris-HCl PH 7.4) on ice for 15 minutes. Cell lysates were added with 734 
Laemmli buffer and ran on SDS-PAGE followed by western blotting to detect proteins by 735 
indicated antibodies: Primary antibodies used include anti-ORC2 (rabbit polyclonal #CS205, in-736 
house), anti-ORC3 (rabbit polyclonal #CS1980, in-house), ani-ORC1 (mouse monoclonal 737 
#pKS1-40, in-house), anti-CDC6 (mouse monoclonal #DCS-180, EMD Millipore), anti-ATM 738 
(rabbit monoclonal #ab32420, abcam), anti-pATM(S1981) (rabbit monoclonal #ab81292, 739 
abcam), anti-CHK1 (rabbit monoclonal #ab40866, abcam), anti-pCHK1(S345) (rabbit polyclonal 740 
#2348, Cell Signaling), anti-pCHK2(T68) (rabbit polyclonal #2197, Cell Signaling), anti-ATR 741 
(rabbit polyclonal #ab2905, abcam), anti-pATR(T1989) (rabbit polyclonal #ab227851, abcam), 742 
anti-pATR(S428) (rabbit polyclonal #2853, Cell Signaling), anti-p-gH2AX(S139) (rabbit 743 
monoclonal #9718, Cell Signaling), anti-b-Actin (mouse monoclonal #3700, Cell Signaling). 744 
Secondary antibodies include ECLTM anti-Rabbit IgG Horseradish Peroxidase linked whole 745 
antibody (#NA934V, GE Healthcare) and ECLTM anti-mouse IgG Horseradish Peroxidase linked 746 
whole antibody (#NA931V, GE Healthcare). 747 
Relative ORC2 (or mAID-ORC2gr) and ORC3 Protein level in each cell line was quantitated by 748 
normalizing band intensity to β-Actin of each cell line and then eventually normalized to HCT116 749 
cells using ImageJ software.  750 
 751 
Cell cycle analysis and pulse EdU label 752 
In double-thymidine block and release experiment, cells were first incubated with 2 mM 753 
thymidine for 18 hours. After 3 times PBS wash, cells were released into fresh media with or 754 
without (0.75 µg/ml) doxycycline for 9 hours. Next, 2 mM thymidine were added into the media 755 
for 16 hours. 500 nM of auxin was added into the medium if needed 4.5 hr. before released. 756 
When released from thymidine block, 0 hr. time point cells were harvest, and the rest were 757 
washed with PBS for 3 times and released into fresh medium ±dox and auxin. Cells were 758 
collected at indicated time point and 10 µM EdU were added into the medium 2 hours before 759 
each harvest (Including time 0). Cells were fixed and processed following Click-iT™ EdU Alexa 760 
Fluor™ 488 Flow Cytometry Assay Kit manufacturer’s manual (ThermoFisher #C10420) and 761 
DNA was stained with FxCycleTM Violet Stain (ThermoFisher #F10347). 762 
 763 
Mitotic index flow cytometry 764 
TO-HCT116 and ORC2_H-2 cells were pre-treated with doxycycline for 24 hr. when needed in 765 
this experiment. Cells were trypsinized and harvest at different time points after auxin treatment, 766 
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and immediately fixed with 4 % Paraformaldehyde in PBS for 15 min, centrifuged at 1000 xg for 767 
7 min. to remove fixation and washed with 1 % BSA-PBS and centrifuged. Next, cells were 768 
permeabilized with 0.5 % triton x-100 in 1 % BSA-PBS for 15 min. at room temperature, 769 
centrifuged, and washed with 1% BSA-PBS and centrifuged. Next, primary antibody anti-770 
pH3S10 antibody (mouse monoclonal #9706, Cell Signaling) were incubated at 37 ̊C for 45 min. 771 
Cells were then washed 3 times in 1 % BSA-PBS +0.1 % NP-40, and incubated with secondary 772 
antibody (Donkey anti-Mouse Alexa Fluor 647 #715-605-151 Jackson ImmunoResearch) at 773 
37 ̊C for 50 min. in the dark. Lastly, after 3 washes cells were incubated with FxCycleTM Violet 774 
Stain (ThermoFisher). The positive/negative gates for pH3S10 were gated on a negative 775 
control, which is unstained cells.  776 
 777 
Cell extraction and MCM2 flow cytometry 778 
EdU-pulse-labeled asynchronous TO-HCT116, ORC2_H-2, ORC2_H-5 cells with or without 779 
doxycycline and auxin treatment were harvest, washed with PBS, and processed based on the 780 
protocol from (Matson et al., 2017)  with slight optimization. In brief, for non-extracted cells, cells 781 
were fixed with 4 % Paraformaldehyde in PBS for 15 min, and then centrifuged at 1000 xg for 7 782 
min. to remove fixation and washed with 1 % BSA-PBS and centrifuged. Next, cells were 783 
permeabilized with 0.5 % triton x-100 in 1 % BSA-PBS for 15 min, centrifuged, and washed with 784 
1% BSA-PBS and centrifuged. For chromatin extracted cells, cells were lysed on ice for 5 min. 785 
in CSK buffer (10mM PIPES/KOH pH 6.8, 100 mM NaCl, 300 mM sucrose, 1 mM EGTA, 1 mM 786 
MgCl2, 1 mM DTT) with 0.5 % triton x-100 with protease and phosphatase inhibitors. Cells were 787 
centrifuged and washed with 1 % BSA-PBS twice and then fixed in 4% paraformaldehyde in 788 
PBS for 15 min. After one wash with PBS, cells were processed following Click-iT™ EdU Alexa 789 
Fluor™ 488 Flow Cytometry Assay Kit manufacturer’s manual (ThermoFisher #C10420), but 790 
instead of saponin-based permeabilization and wash reagent, we used 1 % BSA-PBS +0.1 % 791 
NP-40 for all washing steps. Next, cells were incubated with Anti-MCM2 antibody (mouse 792 
monoclonal #610700, BD Biosciences) at 37 ̊C for 40 min. in the dark. Cells were then washed 793 
3 times in 1 % BSA-PBS +0.1 % NP-40, and incubated with secondary antibody (Donkey anti-794 
Mouse Alexa Fluor 647 #715-605-151 Jackson ImmunoResearch) at 37 ̊C for 50 min. in the 795 
dark. Finally, cells were washed for 3 times and incubated with FxCycleTM Violet Stain 796 
(ThermoFisher). The positive/negative gates for MCM were gated on a negative control, which 797 
is unstained cells. 798 
 799 
Immunofluorescence Staining 800 
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TO-HCT116, ORC2_H-2, ORC2_H-4, and ORC2_H-5 cells were grown on coverslips for 2 days 801 
with or without doxycycline and auxin treatment. When harvest, coverslips were transferred to 6-802 
well plate and rinse with PBS. Cells were fixed in 4 % Paraformaldehyde for 10 min. at room 803 
temperature. Next, cells were washed three times for 5 min. in cold PBS. Cells were then 804 
permeabilized in 0.5 % Triton x-100 -PBS for 9 min. After three PBS wash, cells were blocked 805 
with 5 % normal goat serum (NGS) -PBS +0.1 % Tween for 1 hr. For primary antibody 806 
incubation, antibodies were diluted in 1 % NGS-PBS +0.1 % Tween and incubated for 17 hr. in 807 
the cold room. Primary antibodies used include anti-CENP-C antibody (Mouse monoclonal 808 
#ab50974, Abcam), anti-pCHK1(S345) (rabbit polyclonal #2348, Cell Signaling), anti-p-809 
gH2AX(S139) (rabbit monoclonal #9718, Cell Signaling), and anti-pATM(S1981) (Mouse 810 
monoclonal #ab36180, Abcam). Cells were washed three times for 5 min. in 1 % NGS-PBS 811 
+0.1 % Tween before 1 hr. secondary antibody incubation at room temperature. Secondary 812 
antibodies used are Goat Anti-Mouse IgG H&L Alexa Fluor® 647 (#ab150115, Abcam) and 813 
Goat Anti-Rabbit IgG H&L Alexa Fluor® 488 (#ab150077, Abcam). Next, cells were stained with 814 
1 µg/ml DAPI and mounted with VECTASHIELD® Antifade Mounting Medium (#H-1000-10, 815 
Vector Laboratories). Images were taken using a Perkin Elmer spinning disc confocal equipped 816 
with a Nikon-TiE inverted microscope using 60X objective oil lens with an Orca ER CCD 817 
camera. Images presented are maximum intensity projections of a z-stack (z=0.3µM).  818 
 819 
To study the nuclear and cellular morphology HCT116 p53 WT and p53 null cells and ORC1-/-820 
(B14) and ORC2-/- (P44) cells were plated on coverslips. On day 2 cell were fixed with 4% PFA 821 
and the method described above was followed. Primary antibody against Lamin B1 (Abcam 822 
ab16048) was used as a marker for nuclear envelope. Secondary antibody used is Goat Anti-823 
Rabbit IgG Alexa Fluor® 594 (Abcam ab150084). In addition, Phalloidin iFluor® 488 (Abcam 824 
ab176753) was used to stain for cytoskeleton and DNA was detected with 1µg/ml Hoechst dye 825 
(ThermoFisher #62249). Mounted coverslips were imaged with Perkin Elmer spinning disc 826 
confocal equipped with a Nikon-TiE inverted microscope using 40X objective lens with an Orca 827 
ER CCD camera. Images presented are single channel average intensity projections or merged 828 
multi-channel maximum intensity projections of z-stacks. 829 
 830 
ORC2 Nuclear volume quantitation 831 
Cells nuclear were fixed and stained with DRAQ5™ Fluorescent Probe Solution as per the 832 
manufacturer’s guidelines (ThermoFisher #62251). Images were taken using a Perkin Elmer 833 
spinning disc confocal equipped with a Nikon-TiE inverted microscope using 60X objective lens 834 
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with an Orca ER CCD camera. Images presented are maximum intensity projections of a z-835 
stack (z=0.3µM). Nuclear size was analyzed with volocity software (version 6.3.1). 836 
 837 
Live cell microscopy 838 
TO-HCT116 and ORC2_H-2 cells were seeded in ibidi µ-Slide 8 Well Glass Bottom and in the 839 
presence or absence of 0.75 µg/ml doxycycline for 24 hours. Next, 2 mM thymidine were added 840 
and incubated ±dox for 24 hours. Two hours prior to washing out thymidine, 500 nM auxin were 841 
added to the dox treated wells. Samples were then imaged starting at 4 hours after thymidine 842 
release and the timepoints reconstructed as from a movie using volocity software. Images were 843 
taken using a Perkin Elmer spinning disc confocal equipped with a Nikon-TiE inverted 844 
microscope using 40X objective lens with an Orca ER CCD camera. Images presented are 845 
maximum intensity projections of a z-stack (z=3 µM). Frames were taken approximately every 5 846 
minutes. 847 
 848 
Quantitative PCR 849 
Total RNA of HCT116 p53-/- and ORC2-/- cells were extracted using Rneasy Mini Kit (Qiagen 850 
#74104) following manufacturer’s handbook and quantified by Nanodrop (ThermoFisher). RNA 851 
was then converted to cDNA by doing reverse transcription using oligo(dT) or random hexamer 852 
primers provided by TaqMan Reverse Transcription Reagents (#N8080234, Applied 853 
Biosystems). Primer pairs for quantitative PCR are designed to PCR exon-exon junction 854 
(Supplement Table 3_exon primers) and each PCR was done in triplicates. The delta-Ct (ΔCt) 855 
value was obtained from subtracting Actin mean Ct from each primer pair mean Ct in each cell 856 
line. The delta-delta-Ct (ΔΔCt) value was calculated by subtracting HCT116 p53-/- ΔCt from 857 
ORC2-/- ΔCt for each primer pair individually. Fold change (FC) for each primer pair in ORC2-/- 858 
cells compared to HCT116 p53-/- cells was calculated as FC = 2 (to the power of ΔΔCt). 859 
 860 
Transmission electron microscopy 861 
HCT116 and ORC1-/- cells were harvest and washed twice with PBS. Cells were pelleted and 862 
resuspended in 1 mL of 2.5 % glutaraldehyde in 0.1 M sodium cacodylate solution (pH 7.4) 863 
overnight at 4 °C. Fixative was removed, and in each step, 200 µl of the solution was left in the 864 
tubes. Pellet was washed with 0.1 M sodium cacodylate buffer. Next, 4 % Melt agarose solution 865 
was added to the tube and centrifuged immediately at 1,000 x g for 10 min. at 30 °C, and then 866 
directly transferred the tube to 4 °C or ice for 20 min. to solidify the agarose. Agarose was 867 
washed twice with 0.1 M cacodylate buffer. Next, 1 % osmium tetraoxide (OsO4) solution was 868 
added and let stand for 1 hr. followed by three 0.1 M cacodylate buffer washes. Samples were 869 
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then dehydrated by a graded ethanol series (50 %, 60 %, 70 %, 80 %, 90 %, 95 %, 100 %, 870 
respectively). Finally, samples were embedded in 812 Embed resin and sectioned in 60-90 µM 871 
using Ultramicrotome. Hitachi H-7000 Transmission Electron Microscopy was used to image the 872 
sample. 873 
 874 
Nanopore Long read sequencing and analysis 875 
High molecular weight DNA was isolated using the MagAttract kit (Qiagen # 67563). The quality 876 
of the DNA from the was assessed on femtopulse (Agilent) to ensure DNA fragments were 877 
>40kb on average DNA was sheared to 50kb via Megarupter (diagenode).  After shearing, the 878 
DNA was size selected with a SRE kit (Circulomics) to reduce the fragments <20kb.  After size 879 
selection, the DNA under when a-tailing and damage repair followed by ligation to sequencing 880 
specific adapters. The ½ prepared library was mixed with library loading beads and loaded on to 881 
a PROM-0002 flow-cell and was allowed to sequence for 24 hours.  After 24 hours the flow-882 
cell was treated with DNase to remove stalled DNA followed by a buffer flush. The second ½ of 883 
the library was then loaded and allowed to sequencing for 36 hours.  The DNA was base called 884 
via Guppy 3.2 in High accuracy mode.  Long reads were aligned to the reference human 885 
genome using NGMLR (https://github.com/philres/ngmlr) and structural variants were 886 
identified using Sniffles (https://github.com/fritzsedlazeck/Sniffles) (Sedlazeck et al., 2018). 887 
The alignments and structural variants were then visualized using IGV (https://igv.org/). 888 
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FIGURES AND FIGURE LEGENDS 1230 
Figure 1. 1231 
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 38 
Figure 1. ORC1 is essential to HCT116 and RPE-1 cell lines. (a) tiling sgRNA map ORC1 1233 
(replicate 1) in HCT116. Mapped as Log fold depletion (inverted LFC scale) as calculated by 1234 
MaGeCK (Li et al., 2014) on y axis vs the codon that is disrupted by the guide RNA on the x 1235 
axis. Effect of guide RNA is interpreted as essential if its depletion is more than 1 log fold (red 1236 
dotted line). (b) tiling sgRNA map of ORC1 in RPE-1. Effect of guide RNA is interpreted as 1237 
essential if its depletion is more than 5 log fold (red dotted line). (c) FrPred 1238 
(https://toolkit.tuebingen.mpg.de/frpred) of hORC1 (NP_004144.2) shown as gradient heat map 1239 
of conservation score vs amino acid position. (d) Consurf (https://consurf.tau.ac.il/) of hORC1 – 1240 
(upper) ORC1 (50) subset (50 HMMER Homologues collected from UNIREF90 database, Max 1241 
sequence identity = 95%, Min sequence identity 50, Other parameters = default), and (lower) 1242 
ORC1 (150) subset (150 HMMER Homologues collected from UNIREF90 database, Max 1243 
sequence identity = 95%, Min sequence identity 35, Other parameters = default). Data 1244 
represented as heat map of Conservation scores of each amino acid position. (e) Disopred 1245 
(http://bioinf.cs.ucl.ac.uk/psipred/) plot of hORC1 – heat map representing amino acids within 1246 
intrinsically disordered regions of the protein. (f) Schematic of domain architecture of ORC1. 1247 
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Figure 1—Figure supplement 1. 1249 
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Figure 1—Figure supplement 1. Tiling sgRNA CRISPR screen data and controls. (a) tiling 1251 
sgRNA map of ORC1 (replicate 2) in HCT116. Mapped as Log fold depletion (inverted LFC 1252 
scale) as calculated by MaGeCK (Li et al., 2014) on y axis vs the codon that is disrupted by the 1253 
guide RNA on the x axis. Effect of guide RNA is interpreted as essential if its depletion is more 1254 
than 1 log fold (red dotted line). (b) tiling sgRNA controls for HCT116 (replicate 1). Violin plots 1255 
mapped as distribution of Log fold depletion (MaGeCK) for each guide RNA from for negative 1256 
(NeGeCKO, CTRLS, hROSA, and CSHL-neg library) or positive control (CDK1, CDK9, PCNA, 1257 
POLR2A, POLR2D, RPL9, RPA3, RPL23A, TIP60, TTF2D) subset. The median and quartiles of 1258 
LFC for each subset are indicated within each violin plot. Cut-off of essentiality is LFC ≥ -1, 1259 
indicated by red dotted line (Highest log fold depletion value of all negative controls and more 1260 
than the median of positive controls. (c) tiling sgRNA controls for HCT116 (replicate 2). (d) tiling 1261 
sgRNA controls for RPE-1. Cut-off of essentiality is LFC ≥ -5, indicated by red dotted line. 1262 
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Figure 1—Figure supplement 2. 1264 
 1265 
Figure 1—Figure supplement 2. DepMap analyses of ORC1 data. (a) Distribution of Gene Effect 1266 
scores of ORC1-6 and CDC6 across all the cell lines used in either the GeCKO 19Q1 or Avana 1267 
20Q2 CRISPR screens reported on DepMap [https://doi.org/10.6084/m9.figshare.7668407, 1268 
https://doi.org/10.6084/m9.figshare.12280541.v4; (Meyers et al., 2017b)]. Each box plot 1269 
represents gene effect range displayed in the tested cell lines. The red dotted line represents 1270 
the gene effect score below which genes are scores as essential. (b) ORC1 gene effect values 1271 
for CRISPR (CERES;  (Meyers et al., 2017b) vs RNAi (DepMap, 2019; McFarland et al., 1272 
2018)mapped as xy scatter for ~390 common cell lines used in the screens. Red dotted line 1273 
bifurcates the plot at CRISPR based gene effect score of less than -0.5 is considered essential 1274 
to cell line. Blue dotted line bifurcates the plot at RNAi based gene effect score of less than -0.5 1275 
is considered essential to cell line. (c) Distribution of ORC1 gene effect scores across all the cell 1276 
lines used in CRISPR Avana 20Q2 and RNAi datasets respectively ((McFarland et al., 2018; 1277 
Meyers et al., 2017b). 1278 
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Figure 2. 1279 
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Figure 2. ORC2 is essential in HCT116 and RPE-1 and both by tiling sgRNA and single guide 1281 
CRISPR knock-down in presence of sgRNA-resistant mAID-ORC2gr. (a) tiling sgRNA map of 1282 
ORC2 (replicate 1) in HCT116. Mapped as Log fold depletion (inverted LFC scale) as calculated 1283 
by MaGeCK (Li et al., 2014) on y axis vs the codon that is disrupted by the guide RNA on the x 1284 
axis. Effect of guide RNA is interpreted as essential if its depletion is more than 1 log fold (red 1285 
dotted line). (b) tiling sgRNA map of ORC2 for RPE-1. (c) schematic of ORC2 protein showing 1286 
annotated structural or functional domains. (d) The top panel shows the mAID degron was fused 1287 
to ORC2 transgene at the N-terminus, and the two black boxes indicate ORC2-1 and ORC2-2 1288 
sgRNAs targeting regions. The numbers represent nucleotide positions in the ORC2 cDNA. The 1289 
lower two panels show the comparison of wild type and mAID-ORC2gr with silent mutations at 1290 
the indicated sgRNA targeting sites. The red color marks the mismatches. Protospacer-adjacent 1291 
motif (PAM) site is underlined in the wild type sequence. (e-h) Negative-selection time course 1292 
assay that plots the percentage of GFP positive cells over time following transduction with the 1293 
indicated sgRNAs with Cas9. Experiments were performed in (e) TO-HCT116, (f) U2OS, (g) 1294 
TO-HCT116_mAID-ORC2gr, and (h) U2OS_mAID-ORC2gr cell lines. The GFP positive 1295 
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Figure 2—Figure supplement 1. 1301 
 1302 
Figure 2—Figure supplement 1. (a) Tiling sgRNA map of ORC2 (replicate 2) in HCT116. (b) 1303 
FrPred (https://toolkit.tuebingen.mpg.de/frpred) of hORC2 (NP_006181.1) shown as gradient 1304 
heat map of conservation score vs amino acid position. (d) Consurf (https://consurf.tau.ac.il/) of 1305 
hORC2 – (upper) ORC2 (50) subset (50 HMMER Homologues collected from UNIREF90 1306 
database, Max sequence identity = 95%, Min sequence identity 50, Other parameters = default), 1307 
and (lower) ORC2 (150) subset (150 HMMER Homologues collected from UNIREF90 database, 1308 
Max sequence identity = 95%, Min sequence identity 35, Other parameters = default). Data 1309 
represented as heatmap of Conservation scores of each amino acid position. (e) Disopred 1310 
(http://bioinf.cs.ucl.ac.uk/psipred/) plot of hORC2 – heatmap representing amino acids within 1311 
intrinsically disordered regions of the protein. 1312 
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Figure 2—Figure supplement 2. 1313 
 1314 
Figure 2—Figure supplement 2. (a) Table listing guide RNA sequences used in GeCKO 19Q1 1315 
library against ORC1 and ORC2 that were also present in our tiling sgRNA screen; columns 1316 
HCT116(LFC ≤ -1) and RPE1(LFC ≤-5) show the LFC of the GeCKO guides in our screen. (b) 1317 
Table listing guide RNA sequences used in Avana 20Q2 library against ORC1 and ORC2 that 1318 
were also present in our tiling sgRNA screen; columns HCT116(LFC ≤ -1) and RPE1(LFC ≤-5) 1319 
show the LFC of the GeCKO guides in our screen. Rows highlighted blue represent the only 1320 
common guide against ORC1 used between GeCKO and Avana screens (c) Distribution of the 1321 
LFC values for the GeCKO and Avana guides in HCT116 and RPE-1 (graphical representation 1322 
of the tables (a) & (b). (d) ORC2 guides selected for single guide studies. Row highlighted 1323 
yellow – guide RNA sequence used in the Shibata et. Al 2016 study. 1324 
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Figure 2—Figure supplement 3. 1325 
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Figure 2—Figure supplement 3. Tiling sgRNA CRISPR screen data contd. (a) tiling sgRNA map 1328 
of ORC3 (replicate 1) in HCT116. Mapped as Log fold depletion as calculated by MaGeCK on y 1329 
axis vs the codon that is disrupted by the guide RNA on the x axis. Effect of guide RNA is 1330 
interpreted as essential if its depletion is more than 1 log fold (red dotted line). (b) tiling sgRNA 1331 
map of ORC3 for HCT116 (replicate 2). (c) tiling sgRNA map of ORC3 for RPE-1 cell line. Cutt-1332 
off of essentiality is LFC ≥ -5, indicated by red dotted line. (d) FrPred 1333 
(https://toolkit.tuebingen.mpg.de/frpred) of hORC3 (NP_862820.1) shown as gradient heat map 1334 
of conservation score vs amino acid position. (e) Consurf (https://consurf.tau.ac.il/) of hORC3 – 1335 
(upper) ORC3 (50) subset (50 HMMER Homologues collected from UNIREF90 database, Max 1336 
sequence identity = 95%, Min sequence identity 50, Other parameters = default), and (lower) 1337 
ORC3 (150) subset (150 HMMER Homologues collected from UNIREF90 database, Max 1338 
sequence identity = 95%, Min sequence identity 35, Other parameters = default). Data 1339 
represented as heatmap of Conservation scores of each amino acid position. (f) Disopred 1340 
(http://bioinf.cs.ucl.ac.uk/psipred/) plot of hORC3 – heatmap representing amino acids within 1341 
intrinsically disordered regions of the protein. (g) Schematic of domain architecture of ORC3.  1342 
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Figure 2—Figure supplement 4. 1343 
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Figure 2—Figure supplement 4. Tiling sgRNA CRISPR screen data contd. (a) tiling sgRNA map 1345 
of ORC4 (replicate 1) in HCT116. Mapped as Log fold depletion as calculated by MaGeCK on y 1346 
axis vs the codon that is disrupted by the guide RNA on the x axis. Effect of guide RNA is 1347 
interpreted as essential if its depletion is more than 1 log fold (red dotted line). (b) tiling sgRNA 1348 
map of ORC4 for HCT116 (replicate 2). (c) tiling sgRNA map of ORC4 for RPE-1 cell line. Cutt-1349 
off of essentiality is LFC ≥ -5, indicated by red dotted line. (d) FrPred 1350 
(https://toolkit.tuebingen.mpg.de/frpred) of hORC4 (NP_859525.1) shown as gradient heat map 1351 
of conservation score vs amino acid position. (e) Consurf (https://consurf.tau.ac.il/) of hORC4 – 1352 
(upper) ORC4 (50) subset (50 HMMER Homologues collected from UNIREF90 database, Max 1353 
sequence identity = 95%, Min sequence identity 50, Other parameters = default), and (lower) 1354 
ORC4 (150) subset (150 HMMER Homologues collected from UNIREF90 database, Max 1355 
sequence identity = 95%, Min sequence identity 35, Other parameters = default). Data 1356 
represented as heatmap of Conservation scores of each amino acid position. (f) Disopred 1357 
(http://bioinf.cs.ucl.ac.uk/psipred/) plot of hORC4 – heatmap representing amino acids within 1358 
intrinsically disordered regions of the protein. (g) Schematic of domain architecture of ORC4. (h) 1359 
tiling sgRNA map of ORC5 (replicate 1) in HCT116. (i) tiling sgRNA map of ORC5 for HCT116 1360 
(replicate 2). (j) tiling sgRNA map of ORC5 for RPE-1 cell line. (k) FrPred 1361 
(https://toolkit.tuebingen.mpg.de/frpred) of hORC5 (NP_002544.1) shown as gradient heat map 1362 
of conservation score vs amino acid position. (e) Consurf (https://consurf.tau.ac.il/) of hORC5 – 1363 
(upper) ORC5 (50) subset and (lower) ORC5 (150) subset. Data represented as heatmap of 1364 
Conservation scores of each amino acid position. (f) Disopred (http://bioinf.cs.ucl.ac.uk/psipred/) 1365 
plot of hORC5 – heatmap representing amino acids within intrinsically disordered regions of the 1366 
protein. (g) Schematic of domain architecture of ORC5. 1367 
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Figure 2—Figure supplement 5. 1369 
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Figure 2—Figure supplement 5. Tiling sgRNA CRISPR screen data contd. (a) Tiling sgRNA 1372 
map of ORC6 (replicate 1) in HCT116. Mapped as Log fold depletion as calculated by MaGeCK 1373 
on y axis vs the codon that is disrupted by the guide RNA on the x axis. Effect of guide RNA is 1374 
interpreted as essential if its depletion is more than 1 log fold (red dotted line). (b) Tiling sgRNA 1375 
map of ORC6 for HCT116 (replicate 2). (c) Tiling sgRNA map of ORC6 for RPE-1 cell line. Cutt-1376 
off of essentiality is LFC ≥ -5, indicated by red dotted line. (d) FrPred 1377 
(https://toolkit.tuebingen.mpg.de/frpred) of hORC6 (NP_055136.1) shown as gradient heat map 1378 
of conservation score vs amino acid position. (e) Consurf (https://consurf.tau.ac.il/) of hORC6 – 1379 
(upper) ORC6 (50) subset and (lower) ORC6 (150) (f) Disopred 1380 
(http://bioinf.cs.ucl.ac.uk/psipred/) plot of hORC6-heatmap representing amino acids within 1381 
intrinsically disordered regions of the protein. (g) Schematic of domain architecture of ORC6. (h) 1382 
tiling sgRNA map of CDC6 (replicate 1) in HCT116. (i) Tiling sgRNA map of CDC6 for HCT116 1383 
(replicate 2). (j) Tiling sgRNA map of CDC6 for RPE-1 cell line. (k) FrPred 1384 
(https://toolkit.tuebingen.mpg.de/frpred) of hCDC6 (NP_001245.1) shown as gradient heat map 1385 
of conservation score vs amino acid position. (e) Consurf (https://consurf.tau.ac.il/) of hCDC6 – 1386 
(upper) CDC6 (50) subset and (lower) ORC5 (150) subset. Data represented as heatmap of 1387 
Conservation scores of each amino acid position. (f) Disopred (http://bioinf.cs.ucl.ac.uk/psipred/) 1388 
plot of hCDC6 – heatmap representing amino acids within intrinsically disordered regions of the 1389 
protein. (g) Schematic of domain architecture of hCDC6. 1390 
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Figure 3. 1391 
 1392 
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Figure 3. Characterization of CRISPR/Cas9 ORC2 knockout complemented with sgRNA 1393 
resistant ORC2gr cell lines. (a) Protein level of ORC2, mAID-ORC2gr, and ORC3 in human TO-1394 
HCT116, hTERT-RPE1, human diploid IMR-90 cell line, and three ORC2 KO cell lines. (b-e) 1395 
Cell lines growth rates under (b) normal condition, (c) doxycycline only, (d) auxin only, and (e) 1396 
Dox+auxin containing medium, respectively. The x axis indicates hours after adding doxycycline 1397 
or auxin if any. The y axis reflects the cell number (x105). N = 3 (biological repeats). Error bars, 1398 
mean ± SD. (f) Cell cycle analysis of TO-HCT116, ORC2_H-2, ORC2_H-4, and ORC2_H-5 cell 1399 
lines after mAID-ORC2gr depletion. Cells were treated with 0.75 µg/ml of doxycycline for 24 1400 
hours before auxin treatment. Cells were pulse labeled with 10 μM EdU for 2 hours before 1401 
harvesting at 0, 4, 24, and 50 hr. time points. The x axis indicates DNA content, and the y axis 1402 
refers to EdU incorporation. Overlay plots show colors in different cell cycle phases. (G1-blue; 1403 
S-green; G2/M-orange) (g) Protein expression profile of mAID-ORC2gr, ORC2, ORC1, ORC3, 1404 
CDC6, ATM, p-ATM(S1981), CHK1, p-CHK1(S345), p-CHK2(T68), and p-gH2AX(S139) in 4 cell 1405 
lines after dox and auxin treatment for 0, 4, 24, and 50 hr. Cells were pretreated with 1406 
doxycycline for 24 hr. before auxin treatment. Immunoblots for each protein were developed on 1407 
the same film at the same time for comparison between four cell lines. (h) Immunofluorescent 1408 
staining of p-ATM(S1981) in four cell lines with or without dox+auxin treatment. (i) 1409 
Immunofluorescent staining of p-ATM(S1981) in four cell lines with or without dox+auxin 1410 
treatment. For (h) and (i), dox+auxin treated cells were pre-treated with doxycycline for 24 hr. 1411 
before adding auxin for 48 hours. Scale bar indicated 4 μM. 1412 
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Figure 3—Figure supplement 1. 1414 
 1415 
Figure 3—Figure supplement 1. CRISPR/Cas9 ORC2-1 sgRNA mutagenesis in five cell lines. (a) 1416 
Nucleotide and amino acid alignments near the sgRNA targeting site in parental TO-HCT116 and 1417 
five cloned ORC2 KO cell lines. (b) ORC2_H-2 is resistant to ORC2_1 and ORC2_2 sgRNAs. 1418 
Negative-selection time course assay that plots the percentage of GFP+ cells over time 1419 
following transduction with the indicated sgRNAs with Cas9. The GFP positive percentage was 1420 
normalized to the Day3 measurement. N = 3. Error bars, mean ± SD. 1421 
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Figure 3—Figure supplement 2. 1423 
   1424 
Figure 3—Figure supplement 2. Flow cytometry analysis of cell cycle after dox and auxin 1425 
treatment in TO-HCT116, ORC2_H-2, ORC2_H-4, and ORC2_H-5 cell lines. X axis refers to DNA 1426 
content. Y axis represents the period of time (hr) for auxin treatment. 1427 
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Figure 3—Figure supplement 3. 1429 
 1430 
Figure 3—Figure supplement 3. DNA damage checkpoint was activated in ORC2_H-2, ORC2_H-1431 
4, and ORC2_H-5 cell lines. (a) ATR(T1989) was phosphorylated in ORC2_H-2, -4, -5 cell lines 1432 
after dox and auxin treatment for 50 hours. There was no change in p-ATR(S428) level. (b) 1433 
Phosphorylation of gH2AX(S139) was seen in ORC2_H-2, -4, -5 cell lines either in the absence 1434 
or presence of dox and auxin. 1435 
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Figure 4. 1437 
 1438 
Figure 4. Auxin-treated ORC2_H2, H-4, and H-5 cells had abnormal nuclear phenotypes. (a) 1439 
Nuclear morphology of TO-HCT116, ORC2_H-2 and H-5 cells after 48 hr. auxin treatment. Scale 1440 
bar indicated 4 μM. (b) Scatter plot illustrating the nuclear volume after 48 hr. auxin treatment. 1441 
Untreated: TO-HCT116, n=77; ORC2_H-2, n=52; ORC2_H-5, n=63. Dox and auxin treated: TO-1442 
HCT116, n=66; ORC2_H-2, n=110; ORC2_H-5, n=54. Error bars, medium ± 95% CI. Nuclear 1443 
volume decreased significantly in both dox and auxin treated ORC2_H-2 and H-5 cells. (Student 1444 
t-test, **** p<0.0001) (c) Immunofluorescent staining of CENP-C after mAID-ORC2gr depletion for 1445 
50 hrs. Scale bar indicated 4 μM. 1446 
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Figure 5. ORC2_H-2 cells show abnormal cell cycle progression after mAID-ORC2gr depletion. 1449 
(a) Experimental scheme of TO-HCT116 and ORC2_H-2 cells synchronization by a double 1450 
thymidine block. (b) Flow cytometry analysis of FxCycle™ Violet stained cells (singlets) 1451 
released from double thymidine block in indicated treatment. (c) Cell cycle analysis of TO-1452 
HCT116 and ORC2_H-2 cell lines released from double thymidine block in indicated treatment. 1453 
Cells were pulse labeled with 10μM EdU for 2 hours before harvesting at reported time points. 1454 
The x axis indicates DNA content, and the y axis refers to EdU incorporation. Overlay plots 1455 
show colors in different cell cycle phases. (G1-blue; S-green; G2/M-orange) 1456 
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Figure 5—Figure supplement 1. 1458 
 1459 
Figure 5—Figure supplement 1. Flow cytometry gating. Example of flow cytometry gating for 1460 
Figure 5b and c. First of all, FSC (area) vs SSC (area) gating was used to exclude the cell 1461 
debris. Next, singlets were gated on FxCycle™ Violet (DNA content) height vs area. Cell 1462 
population in G1, S, and G2/M phase was gated on the FxCycle™ Violet (DNA content) area vs 1463 
EdU plot. 1464 
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Figure 6. 1466 
Figure 6. Depletion of mAID-ORC2gr in ORC2_H-2 and H-5 cells result in decreased DNA-loaded 1467 
MCM. (a) Flow cytometry analysis of DNA-bound MCM2 and total MCM2 in asynchronous cells. 1468 
Extracted: Cells were treated with nonionic detergent to wash off unbound MCM2 before fixation, 1469 
and then stained with anti-MCM2 antibody and Alexa Fluor 647- conjugated secondary antibody. 1470 
Non-extracted: Cells were fixed right after harvest and detected for MCM2 with the same 1471 
procedure. Blue cells are MCM2 positive, and red cells are MCM2 negative. The x axis indicates 1472 
DNA content, and the y axis refers to MCM2 level. (b) Flow cytometry measuring DNA content, 1473 
EdU incorporation, and DNA-bound MCM2 in asynchronous cells in different condition. Cells were 1474 
pulse labeled with 10 μM EdU for 2 hours before harvesting. The x axis indicates DNA content, 1475 
and the y axis refers to EdU incorporation. MCM2 positive and negative cells are shown as blue 1476 
and red cells. Numbers at the upper right corner indicates percentage of MCM2 positive 1477 
population. 1478 
 1479 
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Figure 6—Figure supplement 1. 1481 
 1482 
Figure 6—Figure supplement 1. Flow cytometry gating. Example of flow cytometry gating for 1483 
Figure 6. FSC (area) vs SSC (area) gating was used to exclude the cell debris. Next, singlets 1484 
were gated on FxCycle™ Violet (DNA content) height vs area. MCM2 positive population was 1485 
gated on the loaded MCM2 (area) vs SSC (area) of the unstained negative control. Cells stained 1486 
for secondary Donkey anti-Mouse Alexa Fluor 647 antibody only showed minimum background 1487 
for loaded MCM2.  1488 
  1489 
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted August 6, 2020. ; https://doi.org/10.1101/2020.08.06.240358doi: bioRxiv preprint 
 63 
Figure 7. 1490 
1491 
Figure 7. ORC2_H-2 cells have aberrant mitosis after auxin treatment. (a) Mitotic index of TO-1492 
HCT116 and ORC2_H-2 G2/M cells with or without auxin. 0.75 µg/ml Doxycycline were added 1493 
for 24 hr. before auxin treatment. Cells were harvest after 0, 28, or 50 hr. of auxin treatment 1494 
followed by staining with anti-pH3S10 antibody for mitotic cells and FxCycle™ Violet for DNA 1495 
content. The x axis refers to cell line and different conditions, including no treatment, 1496 
doxycycline only, dox+auxin for 28 hr, and dox+auxin for 50 hr. The y axis is the fraction of 4c 1497 
G2/M cells. Cell population positive or negative for p-H3S10 were shown as black or grey color. 1498 
N=3 (biological repeats). (b-e) Time lapse imaging of TO-HCT116 and ORC2_H-2 cell lines. 1499 
Cells were first arrested with single thymidine block (± dox) for 24 hr. and then released into 1500 
desired medium. Time shown in lower left corner indicates time (hour : minute) since early 1501 
prophase. (b) Images of TO-HCT116 cells without auxin were taken at 36 hr. 33 min. after 1502 
released from thymidine block. (c) Auxin treated TO-HCT116 cells were taken at 32 hr. 58 min. 1503 
after released from thymidine block. (d) ORC2_H-2 cells were taken at 41 hr. 38 min. after 1504 
released from thymidine block. (e) Dox and auxin treated ORC2_H-2 cell were taken at 33 hr. 1505 
44 min. after released from thymidine block. White arrows in (e) pointed to the same cell. Scale 1506 
bar indicated 8 μM. 1507 
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Figure 7—Figure supplement 1. 1508 
 1509 
Figure 7—Figure supplement 1. Flow cytometry gating. Example of flow cytometry gating for 1510 
Figure 7a. FSC (area) vs SSC (area) gating was used to exclude the cell debris. Next, singlets 1511 
were gated on FxCycle™ Violet (DNA content) height vs area. Phospho-H3S10 positive 1512 
population was gated on DNA content (height) vs DNA content (area) of the unstained negative 1513 
control cells. G2/M cell population was gated on the DNA content (area) histogram. 1514 
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Figure 8. 1516 
 1517 
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Figure 8. Characterization of previously published ORC1-/- and ORC2-/- cell lines. (a-d) 1518 
Negative-selection time course assay that plots the percentage of GFP+ cells over time 1519 
following transduction with the indicated sgRNAs with Cas9. Experiments were performed in 1520 
HCT116 p53-/-, ORC2-/-, HCT116 p53-/-_mAID-ORC2gr, and ORC2-/-_mAID-ORC2gr cell lines. 1521 
The GFP positive percentage was normalized to the Day3 measurement. n = 3. Error bars, 1522 
mean ± SD. (e) Calculated fold change (FC) for each primer pairs in ORC2-/- cells compared 1523 
to HCT116 p53-/- cells. The red and blue arrows indicate each the primer pair. Two kinds of 1524 
primers, Oligo dT and Random Hexamer, were used in the reverse transcription step. Bar 1525 
diagram view is shown in Figure 8—Figure supplement 1. (f) Structural Variations (SVs) in 1526 
ORC2 gene. Top panel shows the alignment overview of the ONT Promethion long reads over 1527 
the ORC2 gene region with coverage track showing an average coverage of ~50x for the 1528 
majority of the gene sequence, with exceptions in regions around exon 3, 4, and 7. Zoomed-in 1529 
region with heterozygous deletion spanning the exon 7 of the ORC2 gene, with supporting gap 1530 
aligned ONT reads and coverage track with a characteristic “dip” over the deleted segment. 1531 
Zoomed-in rearranged region around exons 3 and 4 of the ORC2 gene, with linked supplement 1532 
read alignments pileup over the affected area supporting the spanning duplication SV, with 2 1533 
more nested inversions and 2 more nested insertion highlighted in the SV track. (g) 1-4: 1534 
Immunofluorescence of HCT116 ORC1-/- (B14) cell line stained with Anti-Lamin B1 antibody 1535 
(Red), Phalloidin (F-actin) (Green), Hoechst Dye (Blue). Images show either merge of all three 1536 
channels or Lamin-B1 staining of the nuclei. White arrows indicate abnormal and involuted 1537 
nuclei in image 1. White arrows also show extremely large (nuclear giants) that have lost 1538 
nuclear membrane integrity (2,4). (h) parental cell line for the ORC1-/- line presented as control 1539 
for quantitative and qualitative comparison. More fields of control cells HCT116 p53 WT and p53 1540 
null background, HCT116 ORC1-/- and HCT116 ORC2-/- cell lines are shown in Figure 8—Figure 1541 
supplement 3 and 4. Scale bar is 25 µm (i) Quantitation of abnormal nuclei between cell lines. 1542 
Significance calculated using two-way ANOVA for multiple comparisons keeping HCT116 p53-/- 1543 
as control. **** p < 0.0001, ** p = 0.0028.  1544 
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Figure 8—Figure supplement 1. 1546 
 1547 
Figure 8—Figure supplement 1. ORC3 exists in ORC2-/- cell line. (a) ORC3 expression in TO-1548 
HCT116, ORC2_H-2, HCT116 p53-/-, HCT116 p53-/-_mAID-ORC2gr, ORC2-/-, and ORC2-/-1549 
_mAID-ORC2gr cell lines. Whole cells were boiled in Laemmli buffer and followed by western 1550 
blotting and detected with anti-ORC3 antibody. (b) ORC3 immunoprecipitation (IP) in HCT116 1551 
p53-/- and ORC2-/- cell lines. Cells were lysed in lysis buffer and incubated with mouse IgG or 1552 
ORC3 mouse monoclonal antibody for immunoprecipitation, followed by western blotting and 1553 
detected with antibodies against ORC2 and ORC3. The loaded input was 2.5% and IP was 1554 
30%. Both short and long exposure of ORC2 detection were shown here. Asterisks (*) indicated 1555 
the putative truncated ORC2 which was only found in ORC2-/- cell line. In the short exposure 1556 
only, arrows pointed to nonspecific bands detected by the anti-ORC2 antibody. 1557 
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Figure 8—Figure supplement 2. 1559 
 1560 
 1561 
Figure 8—Figure supplement 2. Real time quantitative PCR fold change in a bar diagram view. 1562 
Blue, fold change of OligodT primer sample. Grey, fold change of random hexamer sample. The 1563 
exon junctions in the ORC2 cDNA are shown as indicated in Figure 8e and the Fold change 1564 
(FC) for each primer pair in ORC2-/- cells compared to HCT116 p53-/- cells was calculated as FC 1565 
= 2(to the power of ΔΔCt). 1566 
 1567 
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Figure 8—Figure supplement 3. 1569 
 1570 
Figure 8—Figure supplement 3. Copy number analysis of the genomes of four cell lines using 1571 
the SMASH method. The amplification of the ORC2 gene sequences in HCT116 ORC2-/- (P44) 1572 
cells is shown by the green dot and filled arrow. The open arrows show acquired CNVs in the 1573 
ORC1-/- and ORC2-/- cells compared to the parent cells. 1574 
 1575 
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Figure 8—Figure supplement 4. 1577 
 1578 
Figure 8—Figure supplement 4. Confocal Microscopy images of HCT116 cell lines. Imaged 1579 
acquired as z-stack of 25 µm (z = 1µm each). Images presented maximum intensity projections 1580 
in the merge and average intensity projections in single channel images. Channel reference: 1581 
Lamin B1 (Red), F-actin (Green), DNA (blue), DIC (grey) (a) HCT116 p53+/+. (b) HCT116 p53 -/-. 1582 
(c-e) HCT116 ORC1-/- (B14). Scale bar is 25 µm. 1583 
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Figure 8—Figure supplement 5. 1584 
 1585 
Figure 8—Figure supplement 5. Confocal (a-c) and Transmission electron microscopy (d-f) 1586 
(TEM) images of HCT116 cell lines. Confocal: (a-b) HCT116 ORC1-/- (B14), (c) HCT116 ORC2-1587 
/-. Scale bar is 25 µm. TEM: (d) HCT116 p53+/+ cells with 2000x magnification. (e) ORC1-/- cells 1588 
with 2000x magnification. (f) ORC1-/- cells with 1000x magnification. Scale bar in (d-e) is 4 μm. 1589 
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Supplement Table 1. The sequences of all guide RNAs used for gene editing, including those 1590 
directed to ORC1-6 and CDC6 as well as positive and negative guides for the tiling CRISPR 1591 
screens. 1592 
 1593 
Supplement Table 2. Sequence of Barcode primers used for Next Gene Sequencing analysis in 1594 
tiling CRISPR screens. 1595 
 1596 
Supplement Table 3. Primers used for exon analysis qPCR of the ORC2 gene cDNAs from 1597 
various cell lines. 1598 
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